activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2029848	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2029848	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030103	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030104	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030105	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030106	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030107	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030108	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030109	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030110	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030111	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030112	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030113	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030114	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030115	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2030116	CHEMBL886314	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	Inhibition	%	40.0
	2051595	CHEMBL942736	Inhibition of ARK5	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	1503.0	CHEMBL5784	Homo sapiens	Ki	uM	1.503
	2147192	CHEMBL927936	Activity of human ARK5 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	98.0	CHEMBL5784	Homo sapiens	Activity	%	98.0
Not Active	2172620	CHEMBL921638	Inhibition of human recombinant NAUK1 kinase at 10 uM	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1C		CHEMBL427726		Activity			CHEMBL5784	Homo sapiens	Activity		
Not Active	2172631	CHEMBL921638	Inhibition of human recombinant NAUK1 kinase at 10 uM	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582		Activity			CHEMBL5784	Homo sapiens	Activity		
Not Active	2172632	CHEMBL921638	Inhibition of human recombinant NAUK1 kinase at 10 uM	B	COc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402228		Activity			CHEMBL5784	Homo sapiens	Activity		
	2273602	CHEMBL960872	Inhibition of human Nuak1	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1615278	=	IC50	nM	840.0	CHEMBL5784	Homo sapiens	IC50	nM	840.0
	2273603	CHEMBL960872	Inhibition of human Nuak1	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	IC50	nM	2000.0	CHEMBL5784	Homo sapiens	IC50	nM	2000.0
Not Active	2301930	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2301953	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2301978	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2302002	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2302026	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2302050	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2302074	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2302098	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	2302122	CHEMBL966088	Inhibition of ARK5 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	2461675	CHEMBL966175	Inhibition of recombinant ARK5	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	0.95	CHEMBL5784	Homo sapiens	IC50	10'-7g/ml	9.5
	2461693	CHEMBL966175	Inhibition of recombinant ARK5	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	2.2	CHEMBL5784	Homo sapiens	IC50	10'-6g/ml	2.2
	2461694	CHEMBL966175	Inhibition of recombinant ARK5	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	=	IC50	ug.mL-1	4.0	CHEMBL5784	Homo sapiens	IC50	10'-6g/ml	4.0
	2461695	CHEMBL966175	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL5784	Homo sapiens	IC50	10'-5g/ml	1.0
	2461696	CHEMBL966175	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL5784	Homo sapiens	IC50	10'-5g/ml	1.0
	2461697	CHEMBL966175	Inhibition of recombinant ARK5	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	2.6	CHEMBL5784	Homo sapiens	IC50	10'-6g/ml	2.6
	2461698	CHEMBL966175	Inhibition of recombinant ARK5	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	6.6	CHEMBL5784	Homo sapiens	IC50	10'-6g/ml	6.6
	2461699	CHEMBL966175	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	0.35	CHEMBL5784	Homo sapiens	IC50	10'-7g/ml	3.5
	2461700	CHEMBL966175	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	4.0	CHEMBL5784	Homo sapiens	IC50	10'-6g/ml	4.0
	2461701	CHEMBL966175	Inhibition of recombinant ARK5	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	0.75	CHEMBL5784	Homo sapiens	IC50	10'-7g/ml	7.5
	2464989	CHEMBL962086	Inhibition of human recombinant ARK5	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	43000.0	CHEMBL5784	Homo sapiens	IC50	uM	43.0
	2465009	CHEMBL962086	Inhibition of human recombinant ARK5	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc1		CHEMBL507056	=	IC50	nM	3600.0	CHEMBL5784	Homo sapiens	IC50	uM	3.6
	2465010	CHEMBL962086	Inhibition of human recombinant ARK5	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc1		CHEMBL452812	=	IC50	nM	2000.0	CHEMBL5784	Homo sapiens	IC50	uM	2.0
	2465011	CHEMBL962086	Inhibition of human recombinant ARK5	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL509435	=	IC50	nM	4900.0	CHEMBL5784	Homo sapiens	IC50	uM	4.9
	2465012	CHEMBL962086	Inhibition of human recombinant ARK5	B	COc1cc(C2=C(c3cn(CC(O)CO)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453593	=	IC50	nM	34000.0	CHEMBL5784	Homo sapiens	IC50	uM	34.0
	2465013	CHEMBL962086	Inhibition of human recombinant ARK5	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL521201	=	IC50	nM	1800.0	CHEMBL5784	Homo sapiens	IC50	uM	1.8
	2470110	CHEMBL1032253	Inhibition of ARK5 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5784	Homo sapiens	INH	%	10.0
Active	2489297	CHEMBL990376	Inhibition of ARK5	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4c(Br)csc4c32)N1		CHEMBL507188		Activity			CHEMBL5784	Homo sapiens	Activity		
	2490361	CHEMBL1025529	Inhibition of ARK5 at 1 uM	B	CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL481806	=	Inhibition	%	51.0	CHEMBL5784	Homo sapiens	INH	%	51.0
	2567223	CHEMBL973706	Inhibition of human ARK5 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	9.0	CHEMBL5784	Homo sapiens	Activity	%	9.0
	2582032	CHEMBL961570	Inhibition of human ARK5	B	CNC(=N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL488271	=	IC50	nM	9700.0	CHEMBL5784	Homo sapiens	IC50	uM	9.7
	2671904	CHEMBL1026219	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	>	IC50	ug.mL-1	10.0	CHEMBL5784	Homo sapiens	IC50	ug ml-1	10.0
	2671905	CHEMBL1026219	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	>	IC50	ug.mL-1	10.0	CHEMBL5784	Homo sapiens	IC50	ug ml-1	10.0
	2671906	CHEMBL1026219	Inhibition of recombinant ARK5	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	>	IC50	ug.mL-1	10.0	CHEMBL5784	Homo sapiens	IC50	ug ml-1	10.0
	2672272	CHEMBL1026219	Inhibition of recombinant ARK5	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	3.8	CHEMBL5784	Homo sapiens	IC50	ug ml-1	3.8
	2721551	CHEMBL1060959	Inhibition of ARK5 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	2898959	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898960	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898961	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898962	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898963	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898964	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898965	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	240.0	CHEMBL5784	Homo sapiens	Kd	nM	240.0
	2898966	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898967	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898968	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898969	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898970	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898971	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898972	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898973	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898974	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898975	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898976	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898977	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898978	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	180.0	CHEMBL5784	Homo sapiens	Kd	nM	180.0
	2898979	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898980	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1800.0	CHEMBL5784	Homo sapiens	Kd	nM	1800.0
	2898981	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898982	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898983	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898984	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	41.0	CHEMBL5784	Homo sapiens	Kd	nM	41.0
	2898985	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898986	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898987	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898988	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898989	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898990	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898991	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.4	CHEMBL5784	Homo sapiens	Kd	nM	4.4
	2898992	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	460.0	CHEMBL5784	Homo sapiens	Kd	nM	460.0
	2898993	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	48.0	CHEMBL5784	Homo sapiens	Kd	nM	48.0
	2898994	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	200.0	CHEMBL5784	Homo sapiens	Kd	nM	200.0
	2898995	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2898996	CHEMBL1060177	Binding constant for ARK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	2921437	CHEMBL1059260	Inhibition of ARK5 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	2926265	CHEMBL1057658	Inhibition of NUAK1 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	140.0	CHEMBL5784	Homo sapiens	Activity	%	140.0
	2928451	CHEMBL1049949	Inhibition of NUAK1 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	133.0	CHEMBL5784	Homo sapiens	Activity	%	133.0
	3052528	CHEMBL1047779	Residual activity of ARK5 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	101.0	CHEMBL5784	Homo sapiens	Residual activity	%	101.0
	3052780	CHEMBL1046513	Residual activity of ARK5 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	139.0	CHEMBL5784	Homo sapiens	Residual activity	%	139.0
	3054089	CHEMBL1066607	Residual activity of ARK5 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	98.0	CHEMBL5784	Homo sapiens	Residual activity	%	98.0
	3055376	CHEMBL1047779	Residual activity of ARK5 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	88.0	CHEMBL5784	Homo sapiens	Residual activity	%	88.0
	3055628	CHEMBL1046513	Residual activity of ARK5 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	127.0	CHEMBL5784	Homo sapiens	Residual activity	%	127.0
	3056933	CHEMBL1066607	Residual activity of ARK5 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	83.0	CHEMBL5784	Homo sapiens	Residual activity	%	83.0
	3058253	CHEMBL1047779	Residual activity of ARK5 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	91.0	CHEMBL5784	Homo sapiens	Residual activity	%	91.0
	3058505	CHEMBL1046513	Residual activity of ARK5 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	109.0	CHEMBL5784	Homo sapiens	Residual activity	%	109.0
	3072851	CHEMBL1066607	Residual activity of ARK5 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL5784	Homo sapiens	Residual activity	%	94.0
	3213988	CHEMBL1116736	Inhibition of NUAK1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL5784	Homo sapiens	INH	%	4.0
	3224759	CHEMBL1102584	Inhibition of NUAK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	3224992	CHEMBL1102584	Inhibition of NUAK1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	3260090	CHEMBL1115999	Inhibition of NUAK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	37.0	CHEMBL5784	Homo sapiens	Activity	%	37.0
	3261383	CHEMBL1115999	Inhibition of NUAK1 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	39.0	CHEMBL5784	Homo sapiens	Activity	%	39.0
Not Active	3293110	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096459		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293126	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL1096460		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293142	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096466		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293158	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccccc3)ccc21		CHEMBL1096672		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293174	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1ccc(Nc2ccc3c(c2)Cc2ccccc2CC3=O)cc1		CHEMBL1096769		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293190	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)C(=O)Cc1ccccc1C2		CHEMBL1096770		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293206	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1096771		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293222	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1097085		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293238	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	O=C1Cc2ccc(Nc3ccccc3)cc2Cc2ccccc21		CHEMBL1097086		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293254	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097087		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293270	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097088		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293286	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	O=C1Cc2cc(Nc3ccccc3)ccc2Cc2ccccc21		CHEMBL1096988		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293302	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098461		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293318	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098462		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293334	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(-c3ccccc3)ccc21		CHEMBL1096442		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	3293350	CHEMBL1108233	Inhibition of ARK5 at 10 uM	B	O=C1Cc2ccccc2Cc2cc(NCc3ccccc3)ccc21		CHEMBL1097171		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	3331829	CHEMBL1168788	Inhibition of ARK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	Inhibition	%	96.0	CHEMBL5784	Homo sapiens	INH	%	96.0
	3333244	CHEMBL1168788	Inhibition of ARK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Inhibition	%	92.0	CHEMBL5784	Homo sapiens	INH	%	92.0
	3334649	CHEMBL1168788	Inhibition of ARK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	=	Inhibition	%	94.0	CHEMBL5784	Homo sapiens	INH	%	94.0
	3336069	CHEMBL1168788	Inhibition of ARK5 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	92.0	CHEMBL5784	Homo sapiens	INH	%	92.0
	3340597	CHEMBL1168788	Inhibition of ARK5 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	88.0	CHEMBL5784	Homo sapiens	INH	%	88.0
	3342013	CHEMBL1168788	Inhibition of ARK5 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	90.0	CHEMBL5784	Homo sapiens	INH	%	90.0
	3358456	CHEMBL1174070	Inhibition of ARK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL5784	Homo sapiens	INH	%	100.0
	3358898	CHEMBL1174070	Inhibition of ARK5 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	95.0	CHEMBL5784	Homo sapiens	INH	%	95.0
	3434678	CHEMBL1246547	Inhibition of ARK5 at 5 uM	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	Inhibition	%	3.0	CHEMBL5784	Homo sapiens	INH	%	3.0
	3445030	CHEMBL1244726	Binding affinity to ARK5	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.7	CHEMBL5784	Homo sapiens	Kd	nM	3.7
	3448881	CHEMBL1244726	Binding affinity to ARK5	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	41.0	CHEMBL5784	Homo sapiens	Kd	nM	41.0
	3449102	CHEMBL1244726	Binding affinity to ARK5	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	48.0	CHEMBL5784	Homo sapiens	Kd	nM	48.0
	3449103	CHEMBL1244726	Binding affinity to ARK5	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	110.0	CHEMBL5784	Homo sapiens	Kd	nM	110.0
	3449562	CHEMBL1244726	Binding affinity to ARK5	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	3449987	CHEMBL1244726	Binding affinity to ARK5	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	3451206	CHEMBL1244726	Binding affinity to ARK5	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	uM	10.0
	5089653	CHEMBL1633373	Inhibition of NUAK1 at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	5120345	CHEMBL1648175	Inhibition of human ARK5 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	103.0	CHEMBL5784	Homo sapiens	INH	%	103.0
	5133688	CHEMBL1648724	Inhibition of NUAK1 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	5133783	CHEMBL1648724	Inhibition of NUAK1 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	86.0	CHEMBL5784	Homo sapiens	Activity	%	86.0
	5133888	CHEMBL1648724	Inhibition of NUAK1 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	94.0	CHEMBL5784	Homo sapiens	Activity	%	94.0
	5191483	CHEMBL1664098	Inhibition of NUAK1 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	24.0	CHEMBL5784	Homo sapiens	INH	%	24.0
	5191484	CHEMBL1664098	Inhibition of NUAK1 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	5250023	CHEMBL1685567	Inhibition of ARK5 at 0.1 uM	B	CCOc1cc2nnc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL1683030	=	Inhibition	%	23.0	CHEMBL5784	Homo sapiens	INH	%	23.0
	5250024	CHEMBL1685566	Inhibition of ARK5 at 1 uM	B	CCOc1cc2nnc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL1683030	=	Inhibition	%	78.0	CHEMBL5784	Homo sapiens	INH	%	78.0
	6169193	CHEMBL1768971	Inhibition of human ARK5 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	16.0	CHEMBL5784	Homo sapiens	Activity	%	16.0
Not Active	6307607	CHEMBL1816864	Inhibition of recombinant ARK5 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	6307608	CHEMBL1816864	Inhibition of recombinant ARK5 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	6307609	CHEMBL1816864	Inhibition of recombinant ARK5 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	=	IC50	nM	33000.0	CHEMBL5784	Homo sapiens	IC50	uM	33.0
	6307610	CHEMBL1816864	Inhibition of recombinant ARK5 assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	=	IC50	nM	15600.0	CHEMBL5784	Homo sapiens	IC50	uM	15.6
	6341019	CHEMBL1827644	Activity of ARK5 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	6352249	CHEMBL1825897	Inhibition of NUAK1 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	40.0	CHEMBL5784	Homo sapiens	Activity	%	40.0
	7567505	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7567976	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	1500.0	CHEMBL5784	Homo sapiens	Kd	nM	1500.0
	7568444	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7568876	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	460.0	CHEMBL5784	Homo sapiens	Kd	nM	460.0
	7569019	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7569479	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7569951	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7570414	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	620.0	CHEMBL5784	Homo sapiens	Kd	nM	620.0
	7570841	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	48.0	CHEMBL5784	Homo sapiens	Kd	nM	48.0
	7570995	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7571452	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7571928	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7572391	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7572807	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	13.0	CHEMBL5784	Homo sapiens	Kd	nM	13.0
	7572976	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7573433	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7573909	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2300.0	CHEMBL5784	Homo sapiens	Kd	nM	2300.0
	7574378	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	41.0	CHEMBL5784	Homo sapiens	Kd	nM	41.0
	7574954	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	160.0	CHEMBL5784	Homo sapiens	Kd	nM	160.0
	7575415	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7575886	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7576317	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7576928	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7577387	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7577893	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7578298	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	34.0	CHEMBL5784	Homo sapiens	Kd	nM	34.0
	7578936	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7579310	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7579760	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7579792	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7580261	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7580664	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7581294	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7581679	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7582153	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7582617	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7583017	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	200.0	CHEMBL5784	Homo sapiens	Kd	nM	200.0
	7584040	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7584511	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7584973	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	75.0	CHEMBL5784	Homo sapiens	Kd	nM	75.0
	7585377	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7585528	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7585936	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7586382	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7586853	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1800.0	CHEMBL5784	Homo sapiens	Kd	nM	1800.0
	7587307	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7587489	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7587908	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7588361	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7588832	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7589283	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7589454	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7589878	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.7	CHEMBL5784	Homo sapiens	Kd	nM	3.7
	7590345	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7590819	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7591427	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7591849	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	240.0	CHEMBL5784	Homo sapiens	Kd	nM	240.0
	7592321	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7592805	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7593394	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7593829	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7594301	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	420.0	CHEMBL5784	Homo sapiens	Kd	nM	420.0
	7594332	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7594784	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	5900.0	CHEMBL5784	Homo sapiens	Kd	nM	5900.0
	7595362	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7595806	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7596309	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7596756	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7597334	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7597818	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7598288	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5784	Homo sapiens	Kd	nM	10000.0
	7598730	CHEMBL1908785	Binding constant for ARK5 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.4	CHEMBL5784	Homo sapiens	Kd	nM	4.4
	7922672	CHEMBL1918829	Inhibition of human recombinant ARK5 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	61.0	CHEMBL5784	Homo sapiens	INH	%	61.0
	7951334	CHEMBL1926221	Inhibition of recombinant human ARK5	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951335	CHEMBL1926221	Inhibition of recombinant human ARK5	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951336	CHEMBL1926221	Inhibition of recombinant human ARK5	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951337	CHEMBL1926221	Inhibition of recombinant human ARK5	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951338	CHEMBL1926221	Inhibition of recombinant human ARK5	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951339	CHEMBL1926221	Inhibition of recombinant human ARK5	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951340	CHEMBL1926221	Inhibition of recombinant human ARK5	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7951341	CHEMBL1926221	Inhibition of recombinant human ARK5	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	7959673	CHEMBL1932327	Inhibition of ARK5	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL5784	Homo sapiens	IC50	uM	30.0
	7959674	CHEMBL1932327	Inhibition of ARK5	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL5784	Homo sapiens	IC50	uM	30.0
	7969765	CHEMBL1929684	Inhibition of NUAK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	79.0	CHEMBL5784	Homo sapiens	Activity	%	79.0
	7978809	CHEMBL1930062	Inhibition of human NUAK1 at 1 uM	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	80.0	CHEMBL5784	Homo sapiens	INH	%	80.0
	7996675	CHEMBL1944006	Inhibition of ARK5 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	94.0	CHEMBL5784	Homo sapiens	INH	%	94.0
	8048837	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957497	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048838	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cccc5[nH]ncc45)cn3c2Br)CC1		CHEMBL1957498	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048839	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(C#N)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957499	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048840	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL1957500	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048841	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	CNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957502	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048842	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	O=C(NCCN1CCOCC1)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957504	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048843	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	CN(C)CCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957505	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8048844	CHEMBL1959601	Inhibition of ARK5 at 5 to 10 uM	B	COCCCNC(=O)c1cn2cc(-c3cccc4[nH]ncc34)nc(N3CCOCC3)c2n1		CHEMBL1957508	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	8060099	CHEMBL1961274	Inhibition of human recombinant ARK5 expressed in Sf9 cells assessed as autophosphorylation after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL5784	Homo sapiens	IC50	uM	35.0
	8060100	CHEMBL1961274	Inhibition of human recombinant ARK5 expressed in Sf9 cells assessed as autophosphorylation after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	510.0	CHEMBL5784	Homo sapiens	IC50	uM	0.51
	8061254	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.84	CHEMBL5784	Homo sapiens	Inhibition	%	1.84
	8061431	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	27.64	CHEMBL5784	Homo sapiens	Inhibition	%	27.64
	8061762	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.19	CHEMBL5784	Homo sapiens	Inhibition	%	4.19
	8061953	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	8.91	CHEMBL5784	Homo sapiens	Inhibition	%	8.91
	8062177	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	44.53	CHEMBL5784	Homo sapiens	Inhibition	%	44.53
	8062293	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.78	CHEMBL5784	Homo sapiens	Inhibition	%	0.78
	8062679	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.76	CHEMBL5784	Homo sapiens	Inhibition	%	8.76
	8062777	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.31	CHEMBL5784	Homo sapiens	Inhibition	%	4.31
	8063001	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.32	CHEMBL5784	Homo sapiens	Inhibition	%	-0.32
	8063133	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.79	CHEMBL5784	Homo sapiens	Inhibition	%	3.79
	8063300	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-1.07	CHEMBL5784	Homo sapiens	Inhibition	%	-1.07
	8063524	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-2.34	CHEMBL5784	Homo sapiens	Inhibition	%	-2.34
	8063632	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.4	CHEMBL5784	Homo sapiens	Inhibition	%	0.4
	8064038	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.51	CHEMBL5784	Homo sapiens	Inhibition	%	1.51
	8064153	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.88	CHEMBL5784	Homo sapiens	Inhibition	%	4.88
	8064377	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.21	CHEMBL5784	Homo sapiens	Inhibition	%	3.21
	8064587	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.15	CHEMBL5784	Homo sapiens	Inhibition	%	0.15
	8064725	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	18.2	CHEMBL5784	Homo sapiens	Inhibition	%	18.2
	8065115	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.56	CHEMBL5784	Homo sapiens	Inhibition	%	-0.56
	8065231	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.15	CHEMBL5784	Homo sapiens	Inhibition	%	1.15
	8065455	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.02	CHEMBL5784	Homo sapiens	Inhibition	%	3.02
	8065630	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.87	CHEMBL5784	Homo sapiens	Inhibition	%	5.87
	8065969	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	18.7	CHEMBL5784	Homo sapiens	Inhibition	%	18.7
	8066179	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.71	CHEMBL5784	Homo sapiens	Inhibition	%	2.71
	8066315	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	61.48	CHEMBL5784	Homo sapiens	Inhibition	%	61.48
	8066539	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	69.08	CHEMBL5784	Homo sapiens	Inhibition	%	69.08
	8066705	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.04	CHEMBL5784	Homo sapiens	Inhibition	%	0.04
	8067053	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.47	CHEMBL5784	Homo sapiens	Inhibition	%	2.47
	8067228	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.25	CHEMBL5784	Homo sapiens	Inhibition	%	3.25
	8067573	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.02	CHEMBL5784	Homo sapiens	Inhibition	%	-0.02
	8067783	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.47	CHEMBL5784	Homo sapiens	Inhibition	%	4.47
	8068142	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	84.76	CHEMBL5784	Homo sapiens	Inhibition	%	84.76
	8068306	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.75	CHEMBL5784	Homo sapiens	Inhibition	%	0.75
	8068655	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.13	CHEMBL5784	Homo sapiens	Inhibition	%	-1.13
	8068829	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.84	CHEMBL5784	Homo sapiens	Inhibition	%	4.84
	8069053	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.01	CHEMBL5784	Homo sapiens	Inhibition	%	1.01
	8069178	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.09	CHEMBL5784	Homo sapiens	Inhibition	%	1.09
	8069473	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	78.14	CHEMBL5784	Homo sapiens	Inhibition	%	78.14
	8069634	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	7.37	CHEMBL5784	Homo sapiens	Inhibition	%	7.37
	8069858	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.35	CHEMBL5784	Homo sapiens	Inhibition	%	0.35
	8069984	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.02	CHEMBL5784	Homo sapiens	Inhibition	%	2.02
	8070380	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.13	CHEMBL5784	Homo sapiens	Inhibition	%	2.13
	8070505	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.39	CHEMBL5784	Homo sapiens	Inhibition	%	-1.39
	8070803	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	91.9	CHEMBL5784	Homo sapiens	Inhibition	%	91.9
	8071184	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	8.3	CHEMBL5784	Homo sapiens	Inhibition	%	8.3
	8071310	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.78	CHEMBL5784	Homo sapiens	Inhibition	%	0.78
	8071534	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.74	CHEMBL5784	Homo sapiens	Inhibition	%	4.74
	8071707	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-2.45	CHEMBL5784	Homo sapiens	Inhibition	%	-2.45
	8071832	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.75	CHEMBL5784	Homo sapiens	Inhibition	%	0.75
	8072056	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.54	CHEMBL5784	Homo sapiens	Inhibition	%	-0.54
	8072146	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.14	CHEMBL5784	Homo sapiens	Inhibition	%	0.14
	8072370	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-3.14	CHEMBL5784	Homo sapiens	Inhibition	%	-3.14
	8072527	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.53	CHEMBL5784	Homo sapiens	Inhibition	%	-0.53
	8072876	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.04	CHEMBL5784	Homo sapiens	Inhibition	%	1.04
	8073043	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.11	CHEMBL5784	Homo sapiens	Inhibition	%	4.11
	8073392	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-3.55	CHEMBL5784	Homo sapiens	Inhibition	%	-3.55
	8073511	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	21.74	CHEMBL5784	Homo sapiens	Inhibition	%	21.74
	8073735	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	62.19	CHEMBL5784	Homo sapiens	Inhibition	%	62.19
	8073968	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-8.68	CHEMBL5784	Homo sapiens	Inhibition	%	-8.68
	8074120	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.72	CHEMBL5784	Homo sapiens	Inhibition	%	-0.72
	8074474	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	14.8	CHEMBL5784	Homo sapiens	Inhibition	%	14.8
	8074631	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.84	CHEMBL5784	Homo sapiens	Inhibition	%	0.84
	8074982	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	13.22	CHEMBL5784	Homo sapiens	Inhibition	%	13.22
	8075317	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.22	CHEMBL5784	Homo sapiens	Inhibition	%	0.22
	8075554	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.69	CHEMBL5784	Homo sapiens	Inhibition	%	2.69
	8075695	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-9.56	CHEMBL5784	Homo sapiens	Inhibition	%	-9.56
	8075919	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.08	CHEMBL5784	Homo sapiens	Inhibition	%	3.08
	8076061	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.12	CHEMBL5784	Homo sapiens	Inhibition	%	5.12
	8076209	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.97	CHEMBL5784	Homo sapiens	Inhibition	%	2.97
	8076433	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.92	CHEMBL5784	Homo sapiens	Inhibition	%	1.92
	8076567	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	47.5	CHEMBL5784	Homo sapiens	Inhibition	%	47.5
	8076893	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.87	CHEMBL5784	Homo sapiens	Inhibition	%	3.87
	8077140	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	24.4	CHEMBL5784	Homo sapiens	Inhibition	%	24.4
	8077492	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.98	CHEMBL5784	Homo sapiens	Inhibition	%	2.98
	8077643	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	43.51	CHEMBL5784	Homo sapiens	Inhibition	%	43.51
	8078010	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	9.13	CHEMBL5784	Homo sapiens	Inhibition	%	9.13
	8078149	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.73	CHEMBL5784	Homo sapiens	Inhibition	%	2.73
	8078373	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	10.96	CHEMBL5784	Homo sapiens	Inhibition	%	10.96
	8078475	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.54	CHEMBL5784	Homo sapiens	Inhibition	%	0.54
	8078725	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	69.58	CHEMBL5784	Homo sapiens	Inhibition	%	69.58
	8079065	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.37	CHEMBL5784	Homo sapiens	Inhibition	%	2.37
	8079223	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	6.98	CHEMBL5784	Homo sapiens	Inhibition	%	6.98
	8079447	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	39.15	CHEMBL5784	Homo sapiens	Inhibition	%	39.15
	8079589	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.72	CHEMBL5784	Homo sapiens	Inhibition	%	1.72
	8079952	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	31.76	CHEMBL5784	Homo sapiens	Inhibition	%	31.76
	8080057	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.89	CHEMBL5784	Homo sapiens	Inhibition	%	1.89
	8080309	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	29.65	CHEMBL5784	Homo sapiens	Inhibition	%	29.65
	8080533	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	75.64	CHEMBL5784	Homo sapiens	Inhibition	%	75.64
	8080648	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.25	CHEMBL5784	Homo sapiens	Inhibition	%	0.25
	8081036	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.5	CHEMBL5784	Homo sapiens	Inhibition	%	3.5
	8081171	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.16	CHEMBL5784	Homo sapiens	Inhibition	%	2.16
	8081539	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	62.84	CHEMBL5784	Homo sapiens	Inhibition	%	62.84
	8081642	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	8.01	CHEMBL5784	Homo sapiens	Inhibition	%	8.01
	8081866	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	48.34	CHEMBL5784	Homo sapiens	Inhibition	%	48.34
	8082118	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.83	CHEMBL5784	Homo sapiens	Inhibition	%	0.83
	8082231	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-1.38	CHEMBL5784	Homo sapiens	Inhibition	%	-1.38
	8082455	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.55	CHEMBL5784	Homo sapiens	Inhibition	%	-0.55
	8082628	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	8.02	CHEMBL5784	Homo sapiens	Inhibition	%	8.02
	8082751	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.27	CHEMBL5784	Homo sapiens	Inhibition	%	0.27
	8082975	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	5.25	CHEMBL5784	Homo sapiens	Inhibition	%	5.25
	8083131	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	19.35	CHEMBL5784	Homo sapiens	Inhibition	%	19.35
	8083454	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.11	CHEMBL5784	Homo sapiens	Inhibition	%	-0.11
	8083708	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	6.7	CHEMBL5784	Homo sapiens	Inhibition	%	6.7
	8084042	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.58	CHEMBL5784	Homo sapiens	Inhibition	%	5.58
	8084227	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	79.82	CHEMBL5784	Homo sapiens	Inhibition	%	79.82
	8084569	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.17	CHEMBL5784	Homo sapiens	Inhibition	%	1.17
	8084730	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	66.41	CHEMBL5784	Homo sapiens	Inhibition	%	66.41
	8085052	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.95	CHEMBL5784	Homo sapiens	Inhibition	%	1.95
	8085308	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	7.72	CHEMBL5784	Homo sapiens	Inhibition	%	7.72
	8085640	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-2.56	CHEMBL5784	Homo sapiens	Inhibition	%	-2.56
	8085829	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	85.37	CHEMBL5784	Homo sapiens	Inhibition	%	85.37
	8086168	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.46	CHEMBL5784	Homo sapiens	Inhibition	%	3.46
	8086330	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.41	CHEMBL5784	Homo sapiens	Inhibition	%	2.41
	8086554	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	11.96	CHEMBL5784	Homo sapiens	Inhibition	%	11.96
	8086653	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.84	CHEMBL5784	Homo sapiens	Inhibition	%	1.84
	8086864	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1	Outside typical range	CHEMBL263796	=	Inhibition	%	-13.31	CHEMBL5784	Homo sapiens	Inhibition	%	-13.31
	8087088	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	7.27	CHEMBL5784	Homo sapiens	Inhibition	%	7.27
	8087246	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.85	CHEMBL5784	Homo sapiens	Inhibition	%	0.85
	8087584	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-0.18	CHEMBL5784	Homo sapiens	Inhibition	%	-0.18
	8087722	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.56	CHEMBL5784	Homo sapiens	Inhibition	%	4.56
	8087946	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.26	CHEMBL5784	Homo sapiens	Inhibition	%	-1.26
	8088088	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.51	CHEMBL5784	Homo sapiens	Inhibition	%	2.51
	8088236	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-2.25	CHEMBL5784	Homo sapiens	Inhibition	%	-2.25
	8088460	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.62	CHEMBL5784	Homo sapiens	Inhibition	%	1.62
	8088588	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.52	CHEMBL5784	Homo sapiens	Inhibition	%	3.52
	8088905	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	10.05	CHEMBL5784	Homo sapiens	Inhibition	%	10.05
	8089257	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.7	CHEMBL5784	Homo sapiens	Inhibition	%	9.7
	8089405	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	80.28	CHEMBL5784	Homo sapiens	Inhibition	%	80.28
	8089749	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.27	CHEMBL5784	Homo sapiens	Inhibition	%	2.27
	8089929	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-3.0	CHEMBL5784	Homo sapiens	Inhibition	%	-3.0
	8090318	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.31	CHEMBL5784	Homo sapiens	Inhibition	%	5.31
	8090485	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.66	CHEMBL5784	Homo sapiens	Inhibition	%	0.66
	8090848	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.52	CHEMBL5784	Homo sapiens	Inhibition	%	-0.52
	8091053	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.27	CHEMBL5784	Homo sapiens	Inhibition	%	-0.27
	8091414	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	48.41	CHEMBL5784	Homo sapiens	Inhibition	%	48.41
	8091569	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.36	CHEMBL5784	Homo sapiens	Inhibition	%	1.36
	8091909	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-4.21	CHEMBL5784	Homo sapiens	Inhibition	%	-4.21
	8092270	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.38	CHEMBL5784	Homo sapiens	Inhibition	%	2.38
	8092421	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.49	CHEMBL5784	Homo sapiens	Inhibition	%	-0.49
	8092793	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.02	CHEMBL5784	Homo sapiens	Inhibition	%	4.02
	8092922	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	22.41	CHEMBL5784	Homo sapiens	Inhibition	%	22.41
	8093146	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.64	CHEMBL5784	Homo sapiens	Inhibition	%	0.64
	8093234	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.07	CHEMBL5784	Homo sapiens	Inhibition	%	0.07
	8093598	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	28.01	CHEMBL5784	Homo sapiens	Inhibition	%	28.01
	8093737	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	87.32	CHEMBL5784	Homo sapiens	Inhibition	%	87.32
	8093961	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	6.73	CHEMBL5784	Homo sapiens	Inhibition	%	6.73
	8094081	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.46	CHEMBL5784	Homo sapiens	Inhibition	%	1.46
	8094261	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.33	CHEMBL5784	Homo sapiens	Inhibition	%	-1.33
	8094485	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.37	CHEMBL5784	Homo sapiens	Inhibition	%	-1.37
	8094660	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	66.62	CHEMBL5784	Homo sapiens	Inhibition	%	66.62
	8094816	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	20.27	CHEMBL5784	Homo sapiens	Inhibition	%	20.27
	8095040	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.46	CHEMBL5784	Homo sapiens	Inhibition	%	2.46
	8095180	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	10.09	CHEMBL5784	Homo sapiens	Inhibition	%	10.09
	8095383	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.06	CHEMBL5784	Homo sapiens	Inhibition	%	1.06
	8095607	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.39	CHEMBL5784	Homo sapiens	Inhibition	%	-1.39
	8095748	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	69.84	CHEMBL5784	Homo sapiens	Inhibition	%	69.84
	8095896	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.12	CHEMBL5784	Homo sapiens	Inhibition	%	-0.12
	8096120	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.05	CHEMBL5784	Homo sapiens	Inhibition	%	2.05
	8096237	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.1	CHEMBL5784	Homo sapiens	Inhibition	%	0.1
	8096600	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-2.45	CHEMBL5784	Homo sapiens	Inhibition	%	-2.45
	8096756	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.79	CHEMBL5784	Homo sapiens	Inhibition	%	3.79
	8096980	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.88	CHEMBL5784	Homo sapiens	Inhibition	%	1.88
	8097127	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	7.65	CHEMBL5784	Homo sapiens	Inhibition	%	7.65
	8097434	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.25	CHEMBL5784	Homo sapiens	Inhibition	%	3.25
	8097658	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.85	CHEMBL5784	Homo sapiens	Inhibition	%	4.85
	8097808	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	94.5	CHEMBL5784	Homo sapiens	Inhibition	%	94.5
	8098165	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	8.0	CHEMBL5784	Homo sapiens	Inhibition	%	8.0
	8098285	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.73	CHEMBL5784	Homo sapiens	Inhibition	%	-2.73
	8098689	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.16	CHEMBL5784	Homo sapiens	Inhibition	%	-0.16
	8098874	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	85.04	CHEMBL5784	Homo sapiens	Inhibition	%	85.04
	8099242	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.61	CHEMBL5784	Homo sapiens	Inhibition	%	3.61
	8099384	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.05	CHEMBL5784	Homo sapiens	Inhibition	%	-0.05
	8099802	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-2.95	CHEMBL5784	Homo sapiens	Inhibition	%	-2.95
	8099949	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.88	CHEMBL5784	Homo sapiens	Inhibition	%	6.88
	8100319	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.26	CHEMBL5784	Homo sapiens	Inhibition	%	5.26
	8100435	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-0.11	CHEMBL5784	Homo sapiens	Inhibition	%	-0.11
	8100659	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-1.37	CHEMBL5784	Homo sapiens	Inhibition	%	-1.37
	8100799	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-2.99	CHEMBL5784	Homo sapiens	Inhibition	%	-2.99
	8101183	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.44	CHEMBL5784	Homo sapiens	Inhibition	%	5.44
	8101325	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	24.42	CHEMBL5784	Homo sapiens	Inhibition	%	24.42
	8101734	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	15.69	CHEMBL5784	Homo sapiens	Inhibition	%	15.69
	8101987	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	38.5	CHEMBL5784	Homo sapiens	Inhibition	%	38.5
	8102142	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	40.52	CHEMBL5784	Homo sapiens	Inhibition	%	40.52
	8102497	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.96	CHEMBL5784	Homo sapiens	Inhibition	%	5.96
	8102617	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	8.04	CHEMBL5784	Homo sapiens	Inhibition	%	8.04
	8102841	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.37	CHEMBL5784	Homo sapiens	Inhibition	%	-0.37
	8103019	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-1.67	CHEMBL5784	Homo sapiens	Inhibition	%	-1.67
	8103215	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	7.0	CHEMBL5784	Homo sapiens	Inhibition	%	7.0
	8103577	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	22.98	CHEMBL5784	Homo sapiens	Inhibition	%	22.98
	8103727	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.5	CHEMBL5784	Homo sapiens	Inhibition	%	3.5
	8103951	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.7	CHEMBL5784	Homo sapiens	Inhibition	%	0.7
	8104136	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.13	CHEMBL5784	Homo sapiens	Inhibition	%	1.13
	8104284	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	16.18	CHEMBL5784	Homo sapiens	Inhibition	%	16.18
	8104508	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	30.2	CHEMBL5784	Homo sapiens	Inhibition	%	30.2
	8104654	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	35.16	CHEMBL5784	Homo sapiens	Inhibition	%	35.16
	8104992	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.67	CHEMBL5784	Homo sapiens	Inhibition	%	0.67
	8105132	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.46	CHEMBL5784	Homo sapiens	Inhibition	%	1.46
	8105522	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	21.96	CHEMBL5784	Homo sapiens	Inhibition	%	21.96
	8105660	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	60.95	CHEMBL5784	Homo sapiens	Inhibition	%	60.95
	8105884	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.89	CHEMBL5784	Homo sapiens	Inhibition	%	5.89
	8105940	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.95	CHEMBL5784	Homo sapiens	Inhibition	%	1.95
	8106164	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	7.23	CHEMBL5784	Homo sapiens	Inhibition	%	7.23
	8106329	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-1.31	CHEMBL5784	Homo sapiens	Inhibition	%	-1.31
	8106485	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	80.69	CHEMBL5784	Homo sapiens	Inhibition	%	80.69
	8106709	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.71	CHEMBL5784	Homo sapiens	Inhibition	%	6.71
	8106838	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.38	CHEMBL5784	Homo sapiens	Inhibition	%	3.38
	8107183	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.67	CHEMBL5784	Homo sapiens	Inhibition	%	1.67
	8107355	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.04	CHEMBL5784	Homo sapiens	Inhibition	%	-0.04
	8107556	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	47.31	CHEMBL5784	Homo sapiens	Inhibition	%	47.31
	8107780	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.69	CHEMBL5784	Homo sapiens	Inhibition	%	2.69
	8107915	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	58.18	CHEMBL5784	Homo sapiens	Inhibition	%	58.18
	8108297	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	6.22	CHEMBL5784	Homo sapiens	Inhibition	%	6.22
	8108472	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.04	CHEMBL5784	Homo sapiens	Inhibition	%	-0.04
	8108843	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	71.93	CHEMBL5784	Homo sapiens	Inhibition	%	71.93
	8108985	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-2.09	CHEMBL5784	Homo sapiens	Inhibition	%	-2.09
	8109323	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.24	CHEMBL5784	Homo sapiens	Inhibition	%	1.24
	8109453	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.41	CHEMBL5784	Homo sapiens	Inhibition	%	-0.41
	8109677	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.41	CHEMBL5784	Homo sapiens	Inhibition	%	2.41
	8109848	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	66.84	CHEMBL5784	Homo sapiens	Inhibition	%	66.84
	8110204	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	32.72	CHEMBL5784	Homo sapiens	Inhibition	%	32.72
	8110483	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.83	CHEMBL5784	Homo sapiens	Inhibition	%	2.83
	8110649	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.22	CHEMBL5784	Homo sapiens	Inhibition	%	7.22
	8111031	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	10.4	CHEMBL5784	Homo sapiens	Inhibition	%	10.4
	8111154	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.37	CHEMBL5784	Homo sapiens	Inhibition	%	1.37
	8111505	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	6.58	CHEMBL5784	Homo sapiens	Inhibition	%	6.58
	8111671	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.91	CHEMBL5784	Homo sapiens	Inhibition	%	2.91
	8111895	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	19.66	CHEMBL5784	Homo sapiens	Inhibition	%	19.66
	8112100	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	19.16	CHEMBL5784	Homo sapiens	Inhibition	%	19.16
	8112237	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.11	CHEMBL5784	Homo sapiens	Inhibition	%	3.11
	8112461	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.97	CHEMBL5784	Homo sapiens	Inhibition	%	2.97
	8112629	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.82	CHEMBL5784	Homo sapiens	Inhibition	%	0.82
	8112801	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.3	CHEMBL5784	Homo sapiens	Inhibition	%	2.3
	8113177	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.05	CHEMBL5784	Homo sapiens	Inhibition	%	1.05
	8113313	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.72	CHEMBL5784	Homo sapiens	Inhibition	%	-0.72
	8113537	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.49	CHEMBL5784	Homo sapiens	Inhibition	%	0.49
	8113661	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.99	CHEMBL5784	Homo sapiens	Inhibition	%	1.99
	8114001	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.23	CHEMBL5784	Homo sapiens	Inhibition	%	2.23
	8114177	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.13	CHEMBL5784	Homo sapiens	Inhibition	%	0.13
	8114533	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.97	CHEMBL5784	Homo sapiens	Inhibition	%	1.97
	8114809	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.62	CHEMBL5784	Homo sapiens	Inhibition	%	2.62
	8114975	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	5.01	CHEMBL5784	Homo sapiens	Inhibition	%	5.01
	8115199	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.07	CHEMBL5784	Homo sapiens	Inhibition	%	6.07
	8115364	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.57	CHEMBL5784	Homo sapiens	Inhibition	%	2.57
	8115484	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	4.18	CHEMBL5784	Homo sapiens	Inhibition	%	4.18
	8115708	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.92	CHEMBL5784	Homo sapiens	Inhibition	%	2.92
	8115841	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	34.39	CHEMBL5784	Homo sapiens	Inhibition	%	34.39
	8116224	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	58.6	CHEMBL5784	Homo sapiens	Inhibition	%	58.6
	8116427	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	6.16	CHEMBL5784	Homo sapiens	Inhibition	%	6.16
	8116785	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	10.96	CHEMBL5784	Homo sapiens	Inhibition	%	10.96
	8116957	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.44	CHEMBL5784	Homo sapiens	Inhibition	%	2.44
	8117128	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.12	CHEMBL5784	Homo sapiens	Inhibition	%	2.12
	8117352	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	47.42	CHEMBL5784	Homo sapiens	Inhibition	%	47.42
	8117510	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.39	CHEMBL5784	Homo sapiens	Inhibition	%	3.39
	8117864	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.58	CHEMBL5784	Homo sapiens	Inhibition	%	1.58
	8118002	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.44	CHEMBL5784	Homo sapiens	Inhibition	%	2.44
	8118342	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.82	CHEMBL5784	Homo sapiens	Inhibition	%	0.82
	8118514	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.75	CHEMBL5784	Homo sapiens	Inhibition	%	6.75
	8118738	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-0.94	CHEMBL5784	Homo sapiens	Inhibition	%	-0.94
	8118874	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.27	CHEMBL5784	Homo sapiens	Inhibition	%	6.27
	8119145	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.32	CHEMBL5784	Homo sapiens	Inhibition	%	-0.32
	8119528	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	16.14	CHEMBL5784	Homo sapiens	Inhibition	%	16.14
	8119695	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.97	CHEMBL5784	Homo sapiens	Inhibition	%	1.97
	8120038	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.0	CHEMBL5784	Homo sapiens	Inhibition	%	2.0
	8120177	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.23	CHEMBL5784	Homo sapiens	Inhibition	%	-1.23
	8120401	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.59	CHEMBL5784	Homo sapiens	Inhibition	%	1.59
	8120561	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.37	CHEMBL5784	Homo sapiens	Inhibition	%	3.37
	8120762	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	42.94	CHEMBL5784	Homo sapiens	Inhibition	%	42.94
	8121114	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	41.7	CHEMBL5784	Homo sapiens	Inhibition	%	41.7
	8121286	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-3.65	CHEMBL5784	Homo sapiens	Inhibition	%	-3.65
	8121677	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	62.55	CHEMBL5784	Homo sapiens	Inhibition	%	62.55
	8121840	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.8	CHEMBL5784	Homo sapiens	Inhibition	%	7.8
	8122185	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.14	CHEMBL5784	Homo sapiens	Inhibition	%	0.14
	8122323	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.58	CHEMBL5784	Homo sapiens	Inhibition	%	6.58
	8122547	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	59.25	CHEMBL5784	Homo sapiens	Inhibition	%	59.25
	8122667	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.1	CHEMBL5784	Homo sapiens	Inhibition	%	1.1
	8123058	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.68	CHEMBL5784	Homo sapiens	Inhibition	%	4.68
	8123200	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	21.74	CHEMBL5784	Homo sapiens	Inhibition	%	21.74
	8123478	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.12	CHEMBL5784	Homo sapiens	Inhibition	%	4.12
	8123852	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	57.33	CHEMBL5784	Homo sapiens	Inhibition	%	57.33
	8124019	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.39	CHEMBL5784	Homo sapiens	Inhibition	%	2.39
	8124362	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	52.76	CHEMBL5784	Homo sapiens	Inhibition	%	52.76
	8124725	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.29	CHEMBL5784	Homo sapiens	Inhibition	%	-0.29
	8124890	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	4.34	CHEMBL5784	Homo sapiens	Inhibition	%	4.34
	8125091	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-0.89	CHEMBL5784	Homo sapiens	Inhibition	%	-0.89
	8125315	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.95	CHEMBL5784	Homo sapiens	Inhibition	%	3.95
	8125445	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.34	CHEMBL5784	Homo sapiens	Inhibition	%	1.34
	8125613	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-2.64	CHEMBL5784	Homo sapiens	Inhibition	%	-2.64
	8125837	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.93	CHEMBL5784	Homo sapiens	Inhibition	%	2.93
	8126001	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.72	CHEMBL5784	Homo sapiens	Inhibition	%	3.72
	8126165	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	29.11	CHEMBL5784	Homo sapiens	Inhibition	%	29.11
	8126389	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	69.04	CHEMBL5784	Homo sapiens	Inhibition	%	69.04
	8126504	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.77	CHEMBL5784	Homo sapiens	Inhibition	%	1.77
	8126864	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	69.1	CHEMBL5784	Homo sapiens	Inhibition	%	69.1
	8126986	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.78	CHEMBL5784	Homo sapiens	Inhibition	%	0.78
	8127210	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.71	CHEMBL5784	Homo sapiens	Inhibition	%	0.71
	8127377	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.71	CHEMBL5784	Homo sapiens	Inhibition	%	0.71
	8127519	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	65.53	CHEMBL5784	Homo sapiens	Inhibition	%	65.53
	8127743	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.07	CHEMBL5784	Homo sapiens	Inhibition	%	1.07
	8127807	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.33	CHEMBL5784	Homo sapiens	Inhibition	%	4.33
	8128031	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	26.43	CHEMBL5784	Homo sapiens	Inhibition	%	26.43
	8128183	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.62	CHEMBL5784	Homo sapiens	Inhibition	%	1.62
	8128350	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	22.32	CHEMBL5784	Homo sapiens	Inhibition	%	22.32
	8128574	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.61	CHEMBL5784	Homo sapiens	Inhibition	%	4.61
	8128693	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	71.0	CHEMBL5784	Homo sapiens	Inhibition	%	71.0
	8129054	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	13.69	CHEMBL5784	Homo sapiens	Inhibition	%	13.69
	8129225	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.84	CHEMBL5784	Homo sapiens	Inhibition	%	0.84
	8129638	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.11	CHEMBL5784	Homo sapiens	Inhibition	%	0.11
	8129777	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.53	CHEMBL5784	Homo sapiens	Inhibition	%	0.53
	8130162	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.68	CHEMBL5784	Homo sapiens	Inhibition	%	1.68
	8130334	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	5.44	CHEMBL5784	Homo sapiens	Inhibition	%	5.44
	8130718	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	84.33	CHEMBL5784	Homo sapiens	Inhibition	%	84.33
	8130834	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-2.66	CHEMBL5784	Homo sapiens	Inhibition	%	-2.66
	8131058	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.2	CHEMBL5784	Homo sapiens	Inhibition	%	0.2
	8131197	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.09	CHEMBL5784	Homo sapiens	Inhibition	%	4.09
	8131541	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.78	CHEMBL5784	Homo sapiens	Inhibition	%	0.78
	8131708	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	12.48	CHEMBL5784	Homo sapiens	Inhibition	%	12.48
	8132073	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	8.04	CHEMBL5784	Homo sapiens	Inhibition	%	8.04
	8132359	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.7	CHEMBL5784	Homo sapiens	Inhibition	%	0.7
	8132506	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.58	CHEMBL5784	Homo sapiens	Inhibition	%	8.58
	8132898	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.26	CHEMBL5784	Homo sapiens	Inhibition	%	4.26
	8133019	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.31	CHEMBL5784	Homo sapiens	Inhibition	%	3.31
	8133243	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	9.78	CHEMBL5784	Homo sapiens	Inhibition	%	9.78
	8133381	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-1.66	CHEMBL5784	Homo sapiens	Inhibition	%	-1.66
	8133553	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.24	CHEMBL5784	Homo sapiens	Inhibition	%	-0.24
	8133777	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.6	CHEMBL5784	Homo sapiens	Inhibition	%	2.6
	8133957	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	44.45	CHEMBL5784	Homo sapiens	Inhibition	%	44.45
	8134105	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.2	CHEMBL5784	Homo sapiens	Inhibition	%	2.2
	8134329	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.41	CHEMBL5784	Homo sapiens	Inhibition	%	2.41
	8134489	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.47	CHEMBL5784	Homo sapiens	Inhibition	%	-0.47
	8134673	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	12.6	CHEMBL5784	Homo sapiens	Inhibition	%	12.6
	8134897	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	43.91	CHEMBL5784	Homo sapiens	Inhibition	%	43.91
	8135057	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.95	CHEMBL5784	Homo sapiens	Inhibition	%	2.95
	8135396	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.55	CHEMBL5784	Homo sapiens	Inhibition	%	-0.55
	8135537	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.84	CHEMBL5784	Homo sapiens	Inhibition	%	5.84
	8135882	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.87	CHEMBL5784	Homo sapiens	Inhibition	%	3.87
	8136050	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.95	CHEMBL5784	Homo sapiens	Inhibition	%	1.95
	8136274	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.7	CHEMBL5784	Homo sapiens	Inhibition	%	3.7
	8136418	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.79	CHEMBL5784	Homo sapiens	Inhibition	%	1.79
	8136708	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.1	CHEMBL5784	Homo sapiens	Inhibition	%	4.1
	8136843	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.25	CHEMBL5784	Homo sapiens	Inhibition	%	-0.25
	8137067	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	14.95	CHEMBL5784	Homo sapiens	Inhibition	%	14.95
	8137230	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	5.36	CHEMBL5784	Homo sapiens	Inhibition	%	5.36
	8137574	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.16	CHEMBL5784	Homo sapiens	Inhibition	%	2.16
	8137722	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.56	CHEMBL5784	Homo sapiens	Inhibition	%	1.56
	8138112	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.42	CHEMBL5784	Homo sapiens	Inhibition	%	3.42
	8138291	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.06	CHEMBL5784	Homo sapiens	Inhibition	%	0.06
	8138663	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	3.9	CHEMBL5784	Homo sapiens	Inhibition	%	3.9
	8138821	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.78	CHEMBL5784	Homo sapiens	Inhibition	%	-0.78
	8139230	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-1.04	CHEMBL5784	Homo sapiens	Inhibition	%	-1.04
	8139389	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.85	CHEMBL5784	Homo sapiens	Inhibition	%	6.85
	8139727	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.02	CHEMBL5784	Homo sapiens	Inhibition	%	-0.02
	8139868	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.9	CHEMBL5784	Homo sapiens	Inhibition	%	0.9
	8140092	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.1	CHEMBL5784	Homo sapiens	Inhibition	%	3.1
	8140215	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-1.45	CHEMBL5784	Homo sapiens	Inhibition	%	-1.45
	8140598	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.2	CHEMBL5784	Homo sapiens	Inhibition	%	1.2
	8140741	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.25	CHEMBL5784	Homo sapiens	Inhibition	%	3.25
	8141043	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	4.37	CHEMBL5784	Homo sapiens	Inhibition	%	4.37
	8141397	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.19	CHEMBL5784	Homo sapiens	Inhibition	%	0.19
	8141557	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	36.34	CHEMBL5784	Homo sapiens	Inhibition	%	36.34
	8141900	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.93	CHEMBL5784	Homo sapiens	Inhibition	%	2.93
	8142061	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.71	CHEMBL5784	Homo sapiens	Inhibition	%	-0.71
	8142285	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.67	CHEMBL5784	Homo sapiens	Inhibition	%	2.67
	8142453	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	50.52	CHEMBL5784	Homo sapiens	Inhibition	%	50.52
	8142629	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.2	CHEMBL5784	Homo sapiens	Inhibition	%	2.2
	8143002	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	3.92	CHEMBL5784	Homo sapiens	Inhibition	%	3.92
	8143157	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.31	CHEMBL5784	Homo sapiens	Inhibition	%	1.31
	8143381	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-1.87	CHEMBL5784	Homo sapiens	Inhibition	%	-1.87
	8143568	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.51	CHEMBL5784	Homo sapiens	Inhibition	%	3.51
	8143727	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.18	CHEMBL5784	Homo sapiens	Inhibition	%	4.18
	8143951	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.3	CHEMBL5784	Homo sapiens	Inhibition	%	5.3
	8144065	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.46	CHEMBL5784	Homo sapiens	Inhibition	%	-0.46
	8144428	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.96	CHEMBL5784	Homo sapiens	Inhibition	%	-0.96
	8144558	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.01	CHEMBL5784	Homo sapiens	Inhibition	%	1.01
	8144935	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.2	CHEMBL5784	Homo sapiens	Inhibition	%	1.2
	8145072	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.36	CHEMBL5784	Homo sapiens	Inhibition	%	0.36
	8145296	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.65	CHEMBL5784	Homo sapiens	Inhibition	%	2.65
	8145385	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-4.13	CHEMBL5784	Homo sapiens	Inhibition	%	-4.13
	8145733	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.78	CHEMBL5784	Homo sapiens	Inhibition	%	2.78
	8145894	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	9.51	CHEMBL5784	Homo sapiens	Inhibition	%	9.51
	8146118	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	30.19	CHEMBL5784	Homo sapiens	Inhibition	%	30.19
	8146238	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	3.62	CHEMBL5784	Homo sapiens	Inhibition	%	3.62
	8146622	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.84	CHEMBL5784	Homo sapiens	Inhibition	%	1.84
	8146789	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	76.62	CHEMBL5784	Homo sapiens	Inhibition	%	76.62
	8146958	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.87	CHEMBL5784	Homo sapiens	Inhibition	%	0.87
	8147182	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.56	CHEMBL5784	Homo sapiens	Inhibition	%	2.56
	8147324	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.22	CHEMBL5784	Homo sapiens	Inhibition	%	-0.22
	8147701	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.91	CHEMBL5784	Homo sapiens	Inhibition	%	0.91
	8147888	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-1.29	CHEMBL5784	Homo sapiens	Inhibition	%	-1.29
	8148270	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-0.12	CHEMBL5784	Homo sapiens	Inhibition	%	-0.12
	8148384	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.63	CHEMBL5784	Homo sapiens	Inhibition	%	0.63
	8148747	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.39	CHEMBL5784	Homo sapiens	Inhibition	%	4.39
	8148885	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.39	CHEMBL5784	Homo sapiens	Inhibition	%	1.39
	8149109	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.27	CHEMBL5784	Homo sapiens	Inhibition	%	2.27
	8149268	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.1	CHEMBL5784	Homo sapiens	Inhibition	%	0.1
	8149626	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.78	CHEMBL5784	Homo sapiens	Inhibition	%	-0.78
	8149724	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-1.06	CHEMBL5784	Homo sapiens	Inhibition	%	-1.06
	8149948	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.07	CHEMBL5784	Homo sapiens	Inhibition	%	4.07
	8150073	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.89	CHEMBL5784	Homo sapiens	Inhibition	%	0.89
	8150457	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.54	CHEMBL5784	Homo sapiens	Inhibition	%	0.54
	8150577	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-4.85	CHEMBL5784	Homo sapiens	Inhibition	%	-4.85
	8150801	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.71	CHEMBL5784	Homo sapiens	Inhibition	%	0.71
	8150966	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.85	CHEMBL5784	Homo sapiens	Inhibition	%	1.85
	8151129	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	6.51	CHEMBL5784	Homo sapiens	Inhibition	%	6.51
	8151530	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-1.38	CHEMBL5784	Homo sapiens	Inhibition	%	-1.38
	8151668	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.2	CHEMBL5784	Homo sapiens	Inhibition	%	4.2
	8151892	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.71	CHEMBL5784	Homo sapiens	Inhibition	%	2.71
	8152046	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.63	CHEMBL5784	Homo sapiens	Inhibition	%	-0.63
	8152234	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.73	CHEMBL5784	Homo sapiens	Inhibition	%	2.73
	8152616	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	10.96	CHEMBL5784	Homo sapiens	Inhibition	%	10.96
	8152730	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.8	CHEMBL5784	Homo sapiens	Inhibition	%	-0.8
	8152954	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-2.26	CHEMBL5784	Homo sapiens	Inhibition	%	-2.26
	8153093	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.69	CHEMBL5784	Homo sapiens	Inhibition	%	0.69
	8153454	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-0.04	CHEMBL5784	Homo sapiens	Inhibition	%	-0.04
	8153611	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.9	CHEMBL5784	Homo sapiens	Inhibition	%	1.9
	8153968	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.03	CHEMBL5784	Homo sapiens	Inhibition	%	2.03
	8154289	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.56	CHEMBL5784	Homo sapiens	Inhibition	%	1.56
	8154415	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	5.7	CHEMBL5784	Homo sapiens	Inhibition	%	5.7
	8154639	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.21	CHEMBL5784	Homo sapiens	Inhibition	%	7.21
	8154798	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	8.68	CHEMBL5784	Homo sapiens	Inhibition	%	8.68
	8155142	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1	Outside typical range	CHEMBL476351	=	Inhibition	%	-40.8	CHEMBL5784	Homo sapiens	Inhibition	%	-40.8
	8155318	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.16	CHEMBL5784	Homo sapiens	Inhibition	%	0.16
	8155479	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	6.93	CHEMBL5784	Homo sapiens	Inhibition	%	6.93
	8155703	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.37	CHEMBL5784	Homo sapiens	Inhibition	%	1.37
	8155881	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.14	CHEMBL5784	Homo sapiens	Inhibition	%	1.14
	8156243	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.44	CHEMBL5784	Homo sapiens	Inhibition	%	7.44
	8156455	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.09	CHEMBL5784	Homo sapiens	Inhibition	%	2.09
	8156605	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.46	CHEMBL5784	Homo sapiens	Inhibition	%	4.46
	8156829	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	8.2	CHEMBL5784	Homo sapiens	Inhibition	%	8.2
	8156972	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	37.21	CHEMBL5784	Homo sapiens	Inhibition	%	37.21
	8157316	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	31.09	CHEMBL5784	Homo sapiens	Inhibition	%	31.09
	8157457	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	35.42	CHEMBL5784	Homo sapiens	Inhibition	%	35.42
	8157811	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-0.07	CHEMBL5784	Homo sapiens	Inhibition	%	-0.07
	8157972	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.71	CHEMBL5784	Homo sapiens	Inhibition	%	3.71
	8158196	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.88	CHEMBL5784	Homo sapiens	Inhibition	%	0.88
	8158446	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	0.02	CHEMBL5784	Homo sapiens	Inhibition	%	0.02
	8158604	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1	Outside typical range	CHEMBL477182	=	Inhibition	%	-14.54	CHEMBL5784	Homo sapiens	Inhibition	%	-14.54
	8158997	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-2.43	CHEMBL5784	Homo sapiens	Inhibition	%	-2.43
	8159132	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.4	CHEMBL5784	Homo sapiens	Inhibition	%	0.4
	8159476	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.3	CHEMBL5784	Homo sapiens	Inhibition	%	-0.3
	8159607	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	13.87	CHEMBL5784	Homo sapiens	Inhibition	%	13.87
	8159831	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	30.25	CHEMBL5784	Homo sapiens	Inhibition	%	30.25
	8159972	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-1.66	CHEMBL5784	Homo sapiens	Inhibition	%	-1.66
	8160333	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.86	CHEMBL5784	Homo sapiens	Inhibition	%	4.86
	8160483	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	9.02	CHEMBL5784	Homo sapiens	Inhibition	%	9.02
	8160777	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.68	CHEMBL5784	Homo sapiens	Inhibition	%	6.68
	8161151	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	41.61	CHEMBL5784	Homo sapiens	Inhibition	%	41.61
	8161294	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	52.79	CHEMBL5784	Homo sapiens	Inhibition	%	52.79
	8161643	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.82	CHEMBL5784	Homo sapiens	Inhibition	%	0.82
	8161781	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	65.33	CHEMBL5784	Homo sapiens	Inhibition	%	65.33
	8162005	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-3.46	CHEMBL5784	Homo sapiens	Inhibition	%	-3.46
	8162135	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.2	CHEMBL5784	Homo sapiens	Inhibition	%	7.2
	8162519	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	4.39	CHEMBL5784	Homo sapiens	Inhibition	%	4.39
	8162772	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	0.59	CHEMBL5784	Homo sapiens	Inhibition	%	0.59
	8162920	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	69.93	CHEMBL5784	Homo sapiens	Inhibition	%	69.93
	8163313	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.58	CHEMBL5784	Homo sapiens	Inhibition	%	1.58
	8163447	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.97	CHEMBL5784	Homo sapiens	Inhibition	%	0.97
	8163671	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.74	CHEMBL5784	Homo sapiens	Inhibition	%	1.74
	8163794	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.86	CHEMBL5784	Homo sapiens	Inhibition	%	1.86
	8164152	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	59.68	CHEMBL5784	Homo sapiens	Inhibition	%	59.68
	8164292	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.87	CHEMBL5784	Homo sapiens	Inhibition	%	0.87
	8164671	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	38.52	CHEMBL5784	Homo sapiens	Inhibition	%	38.52
	8164815	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	39.86	CHEMBL5784	Homo sapiens	Inhibition	%	39.86
	8165039	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-6.19	CHEMBL5784	Homo sapiens	Inhibition	%	-6.19
	8165109	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.36	CHEMBL5784	Homo sapiens	Inhibition	%	5.36
	8165474	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.41	CHEMBL5784	Homo sapiens	Inhibition	%	3.41
	8165617	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	83.16	CHEMBL5784	Homo sapiens	Inhibition	%	83.16
	8165841	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.19	CHEMBL5784	Homo sapiens	Inhibition	%	1.19
	8165967	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	12.45	CHEMBL5784	Homo sapiens	Inhibition	%	12.45
	8166329	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	12.57	CHEMBL5784	Homo sapiens	Inhibition	%	12.57
	8166459	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.46	CHEMBL5784	Homo sapiens	Inhibition	%	0.46
	8166683	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.27	CHEMBL5784	Homo sapiens	Inhibition	%	2.27
	8166784	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	35.5	CHEMBL5784	Homo sapiens	Inhibition	%	35.5
	8167096	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.2	CHEMBL5784	Homo sapiens	Inhibition	%	5.2
	8167237	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	69.78	CHEMBL5784	Homo sapiens	Inhibition	%	69.78
	8167461	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.54	CHEMBL5784	Homo sapiens	Inhibition	%	5.54
	8167625	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%		CHEMBL5784	Homo sapiens	Inhibition	%	
	8167982	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.03	CHEMBL5784	Homo sapiens	Inhibition	%	2.03
	8168106	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.1	CHEMBL5784	Homo sapiens	Inhibition	%	4.1
	8168330	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	11.27	CHEMBL5784	Homo sapiens	Inhibition	%	11.27
	8168471	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.9	CHEMBL5784	Homo sapiens	Inhibition	%	2.9
	8168607	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.37	CHEMBL5784	Homo sapiens	Inhibition	%	1.37
	8168831	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.7	CHEMBL5784	Homo sapiens	Inhibition	%	0.7
	8168995	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	73.41	CHEMBL5784	Homo sapiens	Inhibition	%	73.41
	8169361	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.46	CHEMBL5784	Homo sapiens	Inhibition	%	2.46
	8169441	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.33	CHEMBL5784	Homo sapiens	Inhibition	%	8.33
	8169665	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	54.22	CHEMBL5784	Homo sapiens	Inhibition	%	54.22
	8169799	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.33	CHEMBL5784	Homo sapiens	Inhibition	%	5.33
	8170168	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.22	CHEMBL5784	Homo sapiens	Inhibition	%	2.22
	8170293	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.52	CHEMBL5784	Homo sapiens	Inhibition	%	4.52
	8170517	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	18.99	CHEMBL5784	Homo sapiens	Inhibition	%	18.99
	8170657	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.78	CHEMBL5784	Homo sapiens	Inhibition	%	6.78
	8171016	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	12.58	CHEMBL5784	Homo sapiens	Inhibition	%	12.58
	8171213	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	10.37	CHEMBL5784	Homo sapiens	Inhibition	%	10.37
	8171430	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	26.89	CHEMBL5784	Homo sapiens	Inhibition	%	26.89
	8171795	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	9.13	CHEMBL5784	Homo sapiens	Inhibition	%	9.13
	8171948	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.92	CHEMBL5784	Homo sapiens	Inhibition	%	3.92
	8172304	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	12.6	CHEMBL5784	Homo sapiens	Inhibition	%	12.6
	8172656	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.74	CHEMBL5784	Homo sapiens	Inhibition	%	-0.74
	8172798	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.34	CHEMBL5784	Homo sapiens	Inhibition	%	4.34
	8173158	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.95	CHEMBL5784	Homo sapiens	Inhibition	%	1.95
	8173323	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	16.1	CHEMBL5784	Homo sapiens	Inhibition	%	16.1
	8173688	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-0.34	CHEMBL5784	Homo sapiens	Inhibition	%	-0.34
	8173999	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	83.47	CHEMBL5784	Homo sapiens	Inhibition	%	83.47
	8174131	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.22	CHEMBL5784	Homo sapiens	Inhibition	%	3.22
	8174355	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	8.1	CHEMBL5784	Homo sapiens	Inhibition	%	8.1
	8174503	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.06	CHEMBL5784	Homo sapiens	Inhibition	%	1.06
	8174849	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.68	CHEMBL5784	Homo sapiens	Inhibition	%	1.68
	8174992	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	37.17	CHEMBL5784	Homo sapiens	Inhibition	%	37.17
	8175352	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	48.87	CHEMBL5784	Homo sapiens	Inhibition	%	48.87
	8175608	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	38.68	CHEMBL5784	Homo sapiens	Inhibition	%	38.68
	8175771	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	20.65	CHEMBL5784	Homo sapiens	Inhibition	%	20.65
	8175995	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	64.23	CHEMBL5784	Homo sapiens	Inhibition	%	64.23
	8176148	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.91	CHEMBL5784	Homo sapiens	Inhibition	%	4.91
	8176297	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1	Outside typical range	CHEMBL69757	=	Inhibition	%	-24.99	CHEMBL5784	Homo sapiens	Inhibition	%	-24.99
	8176521	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	39.51	CHEMBL5784	Homo sapiens	Inhibition	%	39.51
	8176653	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	45.95	CHEMBL5784	Homo sapiens	Inhibition	%	45.95
	8177007	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	7.14	CHEMBL5784	Homo sapiens	Inhibition	%	7.14
	8177149	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.07	CHEMBL5784	Homo sapiens	Inhibition	%	3.07
	8177373	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.08	CHEMBL5784	Homo sapiens	Inhibition	%	5.08
	8177511	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	77.98	CHEMBL5784	Homo sapiens	Inhibition	%	77.98
	8177675	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	54.58	CHEMBL5784	Homo sapiens	Inhibition	%	54.58
	8177899	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.85	CHEMBL5784	Homo sapiens	Inhibition	%	3.85
	8178039	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.71	CHEMBL5784	Homo sapiens	Inhibition	%	4.71
	8178351	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.87	CHEMBL5784	Homo sapiens	Inhibition	%	1.87
	8178702	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.48	CHEMBL5784	Homo sapiens	Inhibition	%	6.48
	8178851	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.26	CHEMBL5784	Homo sapiens	Inhibition	%	4.26
	8179198	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	6.34	CHEMBL5784	Homo sapiens	Inhibition	%	6.34
	8179342	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	18.92	CHEMBL5784	Homo sapiens	Inhibition	%	18.92
	8179566	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	59.52	CHEMBL5784	Homo sapiens	Inhibition	%	59.52
	8179703	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-7.52	CHEMBL5784	Homo sapiens	Inhibition	%	-7.52
	8179960	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.18	CHEMBL5784	Homo sapiens	Inhibition	%	1.18
	8180338	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.43	CHEMBL5784	Homo sapiens	Inhibition	%	2.43
	8180494	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.23	CHEMBL5784	Homo sapiens	Inhibition	%	7.23
	8180866	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	55.6	CHEMBL5784	Homo sapiens	Inhibition	%	55.6
	8180999	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.0	CHEMBL5784	Homo sapiens	Inhibition	%	2.0
	8181223	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.91	CHEMBL5784	Homo sapiens	Inhibition	%	4.91
	8181354	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.3	CHEMBL5784	Homo sapiens	Inhibition	%	6.3
	8181718	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.99	CHEMBL5784	Homo sapiens	Inhibition	%	4.99
	8181857	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	77.28	CHEMBL5784	Homo sapiens	Inhibition	%	77.28
	8182244	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.09	CHEMBL5784	Homo sapiens	Inhibition	%	7.09
	8182384	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.79	CHEMBL5784	Homo sapiens	Inhibition	%	2.79
	8182608	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.57	CHEMBL5784	Homo sapiens	Inhibition	%	1.57
	8182700	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.59	CHEMBL5784	Homo sapiens	Inhibition	%	1.59
	8183046	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	16.9	CHEMBL5784	Homo sapiens	Inhibition	%	16.9
	8183195	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.41	CHEMBL5784	Homo sapiens	Inhibition	%	2.41
	8183419	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	13.38	CHEMBL5784	Homo sapiens	Inhibition	%	13.38
	8183548	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.03	CHEMBL5784	Homo sapiens	Inhibition	%	4.03
	8183914	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	11.04	CHEMBL5784	Homo sapiens	Inhibition	%	11.04
	8184050	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.57	CHEMBL5784	Homo sapiens	Inhibition	%	4.57
	8184316	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.89	CHEMBL5784	Homo sapiens	Inhibition	%	3.89
	8184687	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	6.42	CHEMBL5784	Homo sapiens	Inhibition	%	6.42
	8184844	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-3.69	CHEMBL5784	Homo sapiens	Inhibition	%	-3.69
	8185068	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-0.79	CHEMBL5784	Homo sapiens	Inhibition	%	-0.79
	8185217	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.47	CHEMBL5784	Homo sapiens	Inhibition	%	3.47
	8185572	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.55	CHEMBL5784	Homo sapiens	Inhibition	%	4.55
	8185703	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	34.03	CHEMBL5784	Homo sapiens	Inhibition	%	34.03
	8186066	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.6	CHEMBL5784	Homo sapiens	Inhibition	%	2.6
	8186207	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.92	CHEMBL5784	Homo sapiens	Inhibition	%	3.92
	8186431	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.51	CHEMBL5784	Homo sapiens	Inhibition	%	5.51
	8186595	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.26	CHEMBL5784	Homo sapiens	Inhibition	%	3.26
	8186958	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	14.48	CHEMBL5784	Homo sapiens	Inhibition	%	14.48
	8187056	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.73	CHEMBL5784	Homo sapiens	Inhibition	%	0.73
	8187280	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.46	CHEMBL5784	Homo sapiens	Inhibition	%	2.46
	8187404	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.86	CHEMBL5784	Homo sapiens	Inhibition	%	6.86
	8187776	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.6	CHEMBL5784	Homo sapiens	Inhibition	%	1.6
	8187905	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.73	CHEMBL5784	Homo sapiens	Inhibition	%	5.73
	8188272	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	48.9	CHEMBL5784	Homo sapiens	Inhibition	%	48.9
	8188407	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	14.65	CHEMBL5784	Homo sapiens	Inhibition	%	14.65
	8188631	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	37.42	CHEMBL5784	Homo sapiens	Inhibition	%	37.42
	8188681	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.76	CHEMBL5784	Homo sapiens	Inhibition	%	0.76
	8188905	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.98	CHEMBL5784	Homo sapiens	Inhibition	%	2.98
	8189053	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.43	CHEMBL5784	Homo sapiens	Inhibition	%	7.43
	8189433	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.37	CHEMBL5784	Homo sapiens	Inhibition	%	5.37
	8189582	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.8	CHEMBL5784	Homo sapiens	Inhibition	%	1.8
	8189938	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	12.9	CHEMBL5784	Homo sapiens	Inhibition	%	12.9
	8190070	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.1	CHEMBL5784	Homo sapiens	Inhibition	%	4.1
	8190294	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.09	CHEMBL5784	Homo sapiens	Inhibition	%	6.09
	8190434	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	0.7	CHEMBL5784	Homo sapiens	Inhibition	%	0.7
	8190795	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.51	CHEMBL5784	Homo sapiens	Inhibition	%	1.51
	8190959	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.32	CHEMBL5784	Homo sapiens	Inhibition	%	9.32
	8191321	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	57.87	CHEMBL5784	Homo sapiens	Inhibition	%	57.87
	8191641	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.72	CHEMBL5784	Homo sapiens	Inhibition	%	2.72
	8191763	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	30.68	CHEMBL5784	Homo sapiens	Inhibition	%	30.68
	8192136	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.57	CHEMBL5784	Homo sapiens	Inhibition	%	6.57
	8192265	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.93	CHEMBL5784	Homo sapiens	Inhibition	%	2.93
	8192489	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.45	CHEMBL5784	Homo sapiens	Inhibition	%	5.45
	8192633	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.2	CHEMBL5784	Homo sapiens	Inhibition	%	2.2
	8192993	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.52	CHEMBL5784	Homo sapiens	Inhibition	%	4.52
	8193265	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-0.64	CHEMBL5784	Homo sapiens	Inhibition	%	-0.64
	8193410	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	22.33	CHEMBL5784	Homo sapiens	Inhibition	%	22.33
	8193791	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	35.83	CHEMBL5784	Homo sapiens	Inhibition	%	35.83
	8193940	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	4.51	CHEMBL5784	Homo sapiens	Inhibition	%	4.51
	8194164	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.95	CHEMBL5784	Homo sapiens	Inhibition	%	0.95
	8194295	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.16	CHEMBL5784	Homo sapiens	Inhibition	%	7.16
	8194650	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.44	CHEMBL5784	Homo sapiens	Inhibition	%	4.44
	8194793	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.68	CHEMBL5784	Homo sapiens	Inhibition	%	1.68
	8195150	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.83	CHEMBL5784	Homo sapiens	Inhibition	%	0.83
	8195314	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.94	CHEMBL5784	Homo sapiens	Inhibition	%	2.94
	8195538	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	10.77	CHEMBL5784	Homo sapiens	Inhibition	%	10.77
	8195677	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.72	CHEMBL5784	Homo sapiens	Inhibition	%	3.72
	8195999	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-3.57	CHEMBL5784	Homo sapiens	Inhibition	%	-3.57
	8196116	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.96	CHEMBL5784	Homo sapiens	Inhibition	%	4.96
	8196340	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.29	CHEMBL5784	Homo sapiens	Inhibition	%	5.29
	8196490	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.74	CHEMBL5784	Homo sapiens	Inhibition	%	1.74
	8196842	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	20.15	CHEMBL5784	Homo sapiens	Inhibition	%	20.15
	8196983	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.32	CHEMBL5784	Homo sapiens	Inhibition	%	9.32
	8197207	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.67	CHEMBL5784	Homo sapiens	Inhibition	%	-0.67
	8197344	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	21.24	CHEMBL5784	Homo sapiens	Inhibition	%	21.24
	8197619	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-1.26	CHEMBL5784	Homo sapiens	Inhibition	%	-1.26
	8197759	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	14.31	CHEMBL5784	Homo sapiens	Inhibition	%	14.31
	8197983	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	58.62	CHEMBL5784	Homo sapiens	Inhibition	%	58.62
	8198140	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.54	CHEMBL5784	Homo sapiens	Inhibition	%	0.54
	8198502	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.78	CHEMBL5784	Homo sapiens	Inhibition	%	-0.78
	8198632	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.93	CHEMBL5784	Homo sapiens	Inhibition	%	1.93
	8198987	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	7.39	CHEMBL5784	Homo sapiens	Inhibition	%	7.39
	8199135	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	0.74	CHEMBL5784	Homo sapiens	Inhibition	%	0.74
	8199359	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.76	CHEMBL5784	Homo sapiens	Inhibition	%	1.76
	8199493	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.2	CHEMBL5784	Homo sapiens	Inhibition	%	1.2
	8199880	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.92	CHEMBL5784	Homo sapiens	Inhibition	%	1.92
	8200018	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.56	CHEMBL5784	Homo sapiens	Inhibition	%	5.56
	8200346	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.79	CHEMBL5784	Homo sapiens	Inhibition	%	0.79
	8200685	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	6.98	CHEMBL5784	Homo sapiens	Inhibition	%	6.98
	8200835	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	6.31	CHEMBL5784	Homo sapiens	Inhibition	%	6.31
	8201189	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	63.21	CHEMBL5784	Homo sapiens	Inhibition	%	63.21
	8201548	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.08	CHEMBL5784	Homo sapiens	Inhibition	%	-0.08
	8201681	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.98	CHEMBL5784	Homo sapiens	Inhibition	%	-1.98
	8201960	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.03	CHEMBL5784	Homo sapiens	Inhibition	%	2.03
	8202324	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	3.02	CHEMBL5784	Homo sapiens	Inhibition	%	3.02
	8202491	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.44	CHEMBL5784	Homo sapiens	Inhibition	%	2.44
	8202840	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-3.39	CHEMBL5784	Homo sapiens	Inhibition	%	-3.39
	8202970	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.37	CHEMBL5784	Homo sapiens	Inhibition	%	4.37
	8203194	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	18.48	CHEMBL5784	Homo sapiens	Inhibition	%	18.48
	8203325	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	10.95	CHEMBL5784	Homo sapiens	Inhibition	%	10.95
	8203695	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.66	CHEMBL5784	Homo sapiens	Inhibition	%	-0.66
	8203829	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.38	CHEMBL5784	Homo sapiens	Inhibition	%	3.38
	8204053	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-7.35	CHEMBL5784	Homo sapiens	Inhibition	%	-7.35
	8204219	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	4.1	CHEMBL5784	Homo sapiens	Inhibition	%	4.1
	8204356	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.17	CHEMBL5784	Homo sapiens	Inhibition	%	4.17
	8204580	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	7.44	CHEMBL5784	Homo sapiens	Inhibition	%	7.44
	8204685	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.21	CHEMBL5784	Homo sapiens	Inhibition	%	4.21
	8205024	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	27.65	CHEMBL5784	Homo sapiens	Inhibition	%	27.65
	8205173	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.42	CHEMBL5784	Homo sapiens	Inhibition	%	5.42
	8205397	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	25.56	CHEMBL5784	Homo sapiens	Inhibition	%	25.56
	8205533	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.99	CHEMBL5784	Homo sapiens	Inhibition	%	7.99
	8205896	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.19	CHEMBL5784	Homo sapiens	Inhibition	%	2.19
	8206028	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	4.95	CHEMBL5784	Homo sapiens	Inhibition	%	4.95
	8206252	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.53	CHEMBL5784	Homo sapiens	Inhibition	%	-2.53
	8206304	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.5	CHEMBL5784	Homo sapiens	Inhibition	%	0.5
	8206528	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.0	CHEMBL5784	Homo sapiens	Inhibition	%	1.0
	8206671	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	5.77	CHEMBL5784	Homo sapiens	Inhibition	%	5.77
	8206851	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.04	CHEMBL5784	Homo sapiens	Inhibition	%	3.04
	8207075	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-0.59	CHEMBL5784	Homo sapiens	Inhibition	%	-0.59
	8207201	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-2.86	CHEMBL5784	Homo sapiens	Inhibition	%	-2.86
	8207555	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.05	CHEMBL5784	Homo sapiens	Inhibition	%	8.05
	8207687	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	46.21	CHEMBL5784	Homo sapiens	Inhibition	%	46.21
	8207911	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.52	CHEMBL5784	Homo sapiens	Inhibition	%	8.52
	8208056	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.6	CHEMBL5784	Homo sapiens	Inhibition	%	0.6
	8208412	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.48	CHEMBL5784	Homo sapiens	Inhibition	%	2.48
	8208578	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.78	CHEMBL5784	Homo sapiens	Inhibition	%	7.78
	8208935	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.0	CHEMBL5784	Homo sapiens	Inhibition	%	5.0
	8209040	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.73	CHEMBL5784	Homo sapiens	Inhibition	%	1.73
	8209264	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.9	CHEMBL5784	Homo sapiens	Inhibition	%	2.9
	8209380	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.24	CHEMBL5784	Homo sapiens	Inhibition	%	4.24
	8209754	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.06	CHEMBL5784	Homo sapiens	Inhibition	%	3.06
	8209890	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	12.82	CHEMBL5784	Homo sapiens	Inhibition	%	12.82
	8210114	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	24.0	CHEMBL5784	Homo sapiens	Inhibition	%	24.0
	8210255	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.71	CHEMBL5784	Homo sapiens	Inhibition	%	3.71
	8210615	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	9.14	CHEMBL5784	Homo sapiens	Inhibition	%	9.14
	8210874	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.79	CHEMBL5784	Homo sapiens	Inhibition	%	4.79
	8211018	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	18.41	CHEMBL5784	Homo sapiens	Inhibition	%	18.41
	8211412	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.19	CHEMBL5784	Homo sapiens	Inhibition	%	1.19
	8211535	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.81	CHEMBL5784	Homo sapiens	Inhibition	%	5.81
	8211759	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.38	CHEMBL5784	Homo sapiens	Inhibition	%	4.38
	8211888	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	30.24	CHEMBL5784	Homo sapiens	Inhibition	%	30.24
	8212244	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	11.29	CHEMBL5784	Homo sapiens	Inhibition	%	11.29
	8212385	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.71	CHEMBL5784	Homo sapiens	Inhibition	%	0.71
	8212742	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.1	CHEMBL5784	Homo sapiens	Inhibition	%	3.1
	8212912	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	43.55	CHEMBL5784	Homo sapiens	Inhibition	%	43.55
	8213265	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	13.11	CHEMBL5784	Homo sapiens	Inhibition	%	13.11
	8213593	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.82	CHEMBL5784	Homo sapiens	Inhibition	%	1.82
	8213706	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.19	CHEMBL5784	Homo sapiens	Inhibition	%	5.19
	8213930	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.23	CHEMBL5784	Homo sapiens	Inhibition	%	1.23
	8214077	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.32	CHEMBL5784	Homo sapiens	Inhibition	%	8.32
	8214438	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	71.77	CHEMBL5784	Homo sapiens	Inhibition	%	71.77
	8214572	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	7.76	CHEMBL5784	Homo sapiens	Inhibition	%	7.76
	8214948	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.95	CHEMBL5784	Homo sapiens	Inhibition	%	5.95
	8215199	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.4	CHEMBL5784	Homo sapiens	Inhibition	%	3.4
	8215352	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	47.07	CHEMBL5784	Homo sapiens	Inhibition	%	47.07
	8215576	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.47	CHEMBL5784	Homo sapiens	Inhibition	%	3.47
	8215740	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.94	CHEMBL5784	Homo sapiens	Inhibition	%	1.94
	8216083	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	17.25	CHEMBL5784	Homo sapiens	Inhibition	%	17.25
	8216202	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.18	CHEMBL5784	Homo sapiens	Inhibition	%	-0.18
	8216562	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	16.24	CHEMBL5784	Homo sapiens	Inhibition	%	16.24
	8216700	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.52	CHEMBL5784	Homo sapiens	Inhibition	%	2.52
	8216924	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.55	CHEMBL5784	Homo sapiens	Inhibition	%	1.55
	8217058	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.61	CHEMBL5784	Homo sapiens	Inhibition	%	2.61
	8217232	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.75	CHEMBL5784	Homo sapiens	Inhibition	%	-0.75
	8217456	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.38	CHEMBL5784	Homo sapiens	Inhibition	%	5.38
	8217587	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	14.53	CHEMBL5784	Homo sapiens	Inhibition	%	14.53
	8217912	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.54	CHEMBL5784	Homo sapiens	Inhibition	%	3.54
	8218251	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	8.79	CHEMBL5784	Homo sapiens	Inhibition	%	8.79
	8218378	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	43.94	CHEMBL5784	Homo sapiens	Inhibition	%	43.94
	8218745	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	4.62	CHEMBL5784	Homo sapiens	Inhibition	%	4.62
	8218876	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	41.13	CHEMBL5784	Homo sapiens	Inhibition	%	41.13
	8219100	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.15	CHEMBL5784	Homo sapiens	Inhibition	%	1.15
	8219260	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.16	CHEMBL5784	Homo sapiens	Inhibition	%	7.16
	8219510	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-1.7	CHEMBL5784	Homo sapiens	Inhibition	%	-1.7
	8219895	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.24	CHEMBL5784	Homo sapiens	Inhibition	%	1.24
	8220064	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.45	CHEMBL5784	Homo sapiens	Inhibition	%	1.45
	8220417	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.66	CHEMBL5784	Homo sapiens	Inhibition	%	1.66
	8220531	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.82	CHEMBL5784	Homo sapiens	Inhibition	%	3.82
	8220755	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.17	CHEMBL5784	Homo sapiens	Inhibition	%	1.17
	8220893	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	60.83	CHEMBL5784	Homo sapiens	Inhibition	%	60.83
	8221253	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.2	CHEMBL5784	Homo sapiens	Inhibition	%	10.2
	8221386	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.3	CHEMBL5784	Homo sapiens	Inhibition	%	5.3
	8221775	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.71	CHEMBL5784	Homo sapiens	Inhibition	%	3.71
	8221906	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	54.33	CHEMBL5784	Homo sapiens	Inhibition	%	54.33
	8222130	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.82	CHEMBL5784	Homo sapiens	Inhibition	%	2.82
	8222228	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.25	CHEMBL5784	Homo sapiens	Inhibition	%	2.25
	8222586	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	10.65	CHEMBL5784	Homo sapiens	Inhibition	%	10.65
	8222704	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	77.24	CHEMBL5784	Homo sapiens	Inhibition	%	77.24
	8222928	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.8	CHEMBL5784	Homo sapiens	Inhibition	%	6.8
	8223072	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	9.26	CHEMBL5784	Homo sapiens	Inhibition	%	9.26
	8223425	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.05	CHEMBL5784	Homo sapiens	Inhibition	%	3.05
	8223586	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.64	CHEMBL5784	Homo sapiens	Inhibition	%	3.64
	8223836	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-2.12	CHEMBL5784	Homo sapiens	Inhibition	%	-2.12
	8224060	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.31	CHEMBL5784	Homo sapiens	Inhibition	%	4.31
	8224222	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.1	CHEMBL5784	Homo sapiens	Inhibition	%	5.1
	8224392	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.89	CHEMBL5784	Homo sapiens	Inhibition	%	1.89
	8224616	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-2.28	CHEMBL5784	Homo sapiens	Inhibition	%	-2.28
	8224751	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-1.33	CHEMBL5784	Homo sapiens	Inhibition	%	-1.33
	8225089	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.4	CHEMBL5784	Homo sapiens	Inhibition	%	5.4
	8225223	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.05	CHEMBL5784	Homo sapiens	Inhibition	%	5.05
	8225585	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.41	CHEMBL5784	Homo sapiens	Inhibition	%	4.41
	8225720	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.91	CHEMBL5784	Homo sapiens	Inhibition	%	5.91
	8225944	CHEMBL1961946	GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.61	CHEMBL5784	Homo sapiens	Inhibition	%	2.61
	8226102	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.99	CHEMBL5784	Homo sapiens	Inhibition	%	2.99
	8226451	CHEMBL1961947	GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	9.68	CHEMBL5784	Homo sapiens	Inhibition	%	9.68
	10839426	CHEMBL2015411	Inhibition of NuaK1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	10839653	CHEMBL2016303	Inhibition of NUAK1 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	10.0	CHEMBL5784	Homo sapiens	Activity	%	10.0
	10840508	CHEMBL2015171	Inhibition of NUAK1 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	3.0	CHEMBL5784	Homo sapiens	Activity	%	3.0
Not Active	10912559	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O		CHEMBL2036871		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	10913469	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21		CHEMBL2036725		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	10913485	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036726		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	10913501	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21		CHEMBL2036727		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	10913517	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21		CHEMBL2036728		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	10913533	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036867		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	10913549	CHEMBL2038042	Inhibition of recombinant ARK5 at <10 uM by radiometric kinase assay	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036868		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	10921342	CHEMBL2046173	Inhibition of ARK5 at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	92.0	CHEMBL5784	Homo sapiens	INH	%	92.0
	10921343	CHEMBL2046171	Inhibition of ARK5 at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	<	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	10981545	CHEMBL2067601	Inhibition of human ARK5 at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL5784	Homo sapiens	INH	%	90.0
	10981560	CHEMBL2067586	Inhibition of human ARK5	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	26.0	CHEMBL5784	Homo sapiens	IC50	nM	26.0
	11016404	CHEMBL2092098	Inhibition of ARK5 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016405	CHEMBL2092098	Inhibition of ARK5 at 1 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016406	CHEMBL2092098	Inhibition of ARK5 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016407	CHEMBL2092098	Inhibition of ARK5 at 1 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016408	CHEMBL2092098	Inhibition of ARK5 at 1 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016524	CHEMBL2092415	Inhibition of ARK5 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016525	CHEMBL2092415	Inhibition of ARK5 at 5 uM	B	Cc1nc(N)ncc1-c1cn2cc(CN3CCN(S(C)(=O)=O)CC3)nc2c(N2CCOCC2)n1		CHEMBL2087480	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016526	CHEMBL2092415	Inhibition of ARK5 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3c2Br)CC1		CHEMBL2087491	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016527	CHEMBL2092415	Inhibition of ARK5 at 5 uM	B	Cc1c(CN2CCN(S(C)(=O)=O)CC2)nc2c(N3CCOCC3)nc(-c3cnc(N)nc3)cn12		CHEMBL2087492	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
	11016528	CHEMBL2092415	Inhibition of ARK5 at 5 uM	B	CS(=O)(=O)N1CCN(Cc2cn3c(Cl)c(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087493	<	Inhibition	%	30.0	CHEMBL5784	Homo sapiens	INH	%	30.0
Not Active	12047543	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048334	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048349	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048364	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048379	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048394	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048409	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048424	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048439	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048454	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048469	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048484	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048499	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048514	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048529	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048544	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048559	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048574	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048589	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048604	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152957		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048619	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048634	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152959		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048649	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12048664	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049608	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049623	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049638	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049653	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049668	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21		CHEMBL2152970		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049683	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049698	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152972		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Not Active	12049713	CHEMBL2155537	Inhibition of ARK5 at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	12112563	CHEMBL2174333	Inhibition of NUAK1 using [33P]ATP at 0.5 uM by filter-binding assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	>	Inhibition	%	80.0	CHEMBL5784	Homo sapiens	INH	%	80.0
	12170766	CHEMBL2209893	Inhibition of NUAK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	71.0	CHEMBL5784	Homo sapiens	Activity	%	71.0
	12170897	CHEMBL2213456	Inhibition of NUAK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	58.0	CHEMBL5784	Homo sapiens	Activity	%	58.0
	12173736	CHEMBL2212074	Inhibition of ARK5 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	50.0	CHEMBL5784	Homo sapiens	Activity	%	50.0
	12238223	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	116.0	CHEMBL5784	Homo sapiens	Residual Activity	%	116.0
	12238224	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	83.0	CHEMBL5784	Homo sapiens	Residual Activity	%	83.0
	12238225	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12238226	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12238227	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	100.0	CHEMBL5784	Homo sapiens	Residual Activity	%	100.0
	12238228	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238229	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	18.0	CHEMBL5784	Homo sapiens	Residual Activity	%	18.0
	12238230	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12238231	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	116.0	CHEMBL5784	Homo sapiens	Residual Activity	%	116.0
	12238232	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238233	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	95.0	CHEMBL5784	Homo sapiens	Residual Activity	%	95.0
	12238234	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238235	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238236	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12238237	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	45.0	CHEMBL5784	Homo sapiens	Residual Activity	%	45.0
	12238238	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	88.0	CHEMBL5784	Homo sapiens	Residual Activity	%	88.0
	12238239	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	121.0	CHEMBL5784	Homo sapiens	Residual Activity	%	121.0
	12238240	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	107.0	CHEMBL5784	Homo sapiens	Residual Activity	%	107.0
	12238241	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12238242	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	8.0	CHEMBL5784	Homo sapiens	Residual Activity	%	8.0
	12238243	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	98.0	CHEMBL5784	Homo sapiens	Residual Activity	%	98.0
	12238244	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12238245	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	107.0	CHEMBL5784	Homo sapiens	Residual Activity	%	107.0
	12238246	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238247	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	95.0	CHEMBL5784	Homo sapiens	Residual Activity	%	95.0
	12238248	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12238249	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	65.0	CHEMBL5784	Homo sapiens	Residual Activity	%	65.0
	12238250	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	78.0	CHEMBL5784	Homo sapiens	Residual Activity	%	78.0
	12238251	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	107.0	CHEMBL5784	Homo sapiens	Residual Activity	%	107.0
	12238252	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238253	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238254	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238255	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	113.0	CHEMBL5784	Homo sapiens	Residual Activity	%	113.0
	12238256	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12238257	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238258	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238259	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12238260	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238261	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12238262	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	70.0	CHEMBL5784	Homo sapiens	Residual Activity	%	70.0
	12238263	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL5784	Homo sapiens	Residual Activity	%	115.0
	12238264	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12238265	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12238266	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12238267	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	81.0	CHEMBL5784	Homo sapiens	Residual Activity	%	81.0
	12238268	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12238269	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	114.0	CHEMBL5784	Homo sapiens	Residual Activity	%	114.0
	12238270	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	35.0	CHEMBL5784	Homo sapiens	Residual Activity	%	35.0
	12238271	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	118.0	CHEMBL5784	Homo sapiens	Residual Activity	%	118.0
	12238272	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL5784	Homo sapiens	Residual Activity	%	98.0
	12238273	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	37.0	CHEMBL5784	Homo sapiens	Residual Activity	%	37.0
	12238274	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	83.0	CHEMBL5784	Homo sapiens	Residual Activity	%	83.0
	12238275	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	6.0	CHEMBL5784	Homo sapiens	Residual Activity	%	6.0
	12238276	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	95.0	CHEMBL5784	Homo sapiens	Residual Activity	%	95.0
	12238277	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	100.0	CHEMBL5784	Homo sapiens	Residual Activity	%	100.0
	12238278	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	96.0	CHEMBL5784	Homo sapiens	Residual Activity	%	96.0
	12238279	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	113.0	CHEMBL5784	Homo sapiens	Residual Activity	%	113.0
	12238280	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12238281	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	89.0	CHEMBL5784	Homo sapiens	Residual Activity	%	89.0
	12238282	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12238283	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	69.0	CHEMBL5784	Homo sapiens	Residual Activity	%	69.0
	12238284	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	7.0	CHEMBL5784	Homo sapiens	Residual Activity	%	7.0
	12238285	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12238286	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12238287	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	109.0	CHEMBL5784	Homo sapiens	Residual Activity	%	109.0
	12238288	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	93.0	CHEMBL5784	Homo sapiens	Residual Activity	%	93.0
	12238289	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	93.0	CHEMBL5784	Homo sapiens	Residual Activity	%	93.0
	12238290	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238291	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12238292	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	104.0	CHEMBL5784	Homo sapiens	Residual Activity	%	104.0
	12238293	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	92.0	CHEMBL5784	Homo sapiens	Residual Activity	%	92.0
	12238294	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	26.0	CHEMBL5784	Homo sapiens	Residual Activity	%	26.0
	12238295	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	35.0	CHEMBL5784	Homo sapiens	Residual Activity	%	35.0
	12238296	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	107.0	CHEMBL5784	Homo sapiens	Residual Activity	%	107.0
	12238297	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	74.0	CHEMBL5784	Homo sapiens	Residual Activity	%	74.0
	12238298	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	30.0	CHEMBL5784	Homo sapiens	Residual Activity	%	30.0
	12238299	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238300	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	6.0	CHEMBL5784	Homo sapiens	Residual Activity	%	6.0
	12238301	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	103.0	CHEMBL5784	Homo sapiens	Residual Activity	%	103.0
	12238302	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	8.0	CHEMBL5784	Homo sapiens	Residual Activity	%	8.0
	12238303	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12238304	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	4.0	CHEMBL5784	Homo sapiens	Residual Activity	%	4.0
	12238305	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	52.0	CHEMBL5784	Homo sapiens	Residual Activity	%	52.0
	12238306	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12238307	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12238308	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL5784	Homo sapiens	Residual Activity	%	96.0
	12238309	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12238310	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12238311	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12238312	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	4.0	CHEMBL5784	Homo sapiens	Residual Activity	%	4.0
	12238313	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	103.0	CHEMBL5784	Homo sapiens	Residual Activity	%	103.0
	12238314	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12238315	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	3.0	CHEMBL5784	Homo sapiens	Residual Activity	%	3.0
	12238316	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	111.0	CHEMBL5784	Homo sapiens	Residual Activity	%	111.0
	12238317	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	110.0	CHEMBL5784	Homo sapiens	Residual Activity	%	110.0
	12238318	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12238319	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12238320	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	109.0	CHEMBL5784	Homo sapiens	Residual Activity	%	109.0
	12238321	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	108.0	CHEMBL5784	Homo sapiens	Residual Activity	%	108.0
	12238322	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	100.0	CHEMBL5784	Homo sapiens	Residual Activity	%	100.0
	12238323	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	15.0	CHEMBL5784	Homo sapiens	Residual Activity	%	15.0
	12238324	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL5784	Homo sapiens	Residual Activity	%	1.0
	12238325	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	109.0	CHEMBL5784	Homo sapiens	Residual Activity	%	109.0
	12238326	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	39.0	CHEMBL5784	Homo sapiens	Residual Activity	%	39.0
	12238327	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12238328	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238329	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12238330	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12238331	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12238332	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	13.0	CHEMBL5784	Homo sapiens	Residual Activity	%	13.0
	12238333	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	103.0	CHEMBL5784	Homo sapiens	Residual Activity	%	103.0
	12238334	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12238335	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12238336	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12238337	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	98.0	CHEMBL5784	Homo sapiens	Residual Activity	%	98.0
	12238338	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12240932	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	29.0	CHEMBL5784	Homo sapiens	Residual Activity	%	29.0
	12240933	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	100.0	CHEMBL5784	Homo sapiens	Residual Activity	%	100.0
	12240934	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	111.0	CHEMBL5784	Homo sapiens	Residual Activity	%	111.0
	12240935	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	113.0	CHEMBL5784	Homo sapiens	Residual Activity	%	113.0
	12240936	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	12.0	CHEMBL5784	Homo sapiens	Residual Activity	%	12.0
	12240937	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	38.0	CHEMBL5784	Homo sapiens	Residual Activity	%	38.0
	12240938	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	75.0	CHEMBL5784	Homo sapiens	Residual Activity	%	75.0
	12240939	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12240940	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL5784	Homo sapiens	Residual Activity	%	2.0
	12240941	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12240942	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12240943	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	107.0	CHEMBL5784	Homo sapiens	Residual Activity	%	107.0
	12240944	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	15.0	CHEMBL5784	Homo sapiens	Residual Activity	%	15.0
	12240945	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL5784	Homo sapiens	Residual Activity	%	1.0
	12240946	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	107.0	CHEMBL5784	Homo sapiens	Residual Activity	%	107.0
	12240947	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	110.0	CHEMBL5784	Homo sapiens	Residual Activity	%	110.0
	12240948	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	28.0	CHEMBL5784	Homo sapiens	Residual Activity	%	28.0
	12240949	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL5784	Homo sapiens	Residual Activity	%	96.0
	12240950	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	31.0	CHEMBL5784	Homo sapiens	Residual Activity	%	31.0
	12240951	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	44.0	CHEMBL5784	Homo sapiens	Residual Activity	%	44.0
	12240952	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12240953	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	2.0	CHEMBL5784	Homo sapiens	Residual Activity	%	2.0
	12240954	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	11.0	CHEMBL5784	Homo sapiens	Residual Activity	%	11.0
	12240955	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	57.0	CHEMBL5784	Homo sapiens	Residual Activity	%	57.0
	12240956	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	106.0	CHEMBL5784	Homo sapiens	Residual Activity	%	106.0
	12240957	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	42.0	CHEMBL5784	Homo sapiens	Residual Activity	%	42.0
	12240958	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	73.0	CHEMBL5784	Homo sapiens	Residual Activity	%	73.0
	12240959	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	47.0	CHEMBL5784	Homo sapiens	Residual Activity	%	47.0
	12240960	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12240961	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	96.0	CHEMBL5784	Homo sapiens	Residual Activity	%	96.0
	12240962	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	56.0	CHEMBL5784	Homo sapiens	Residual Activity	%	56.0
	12240963	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12240964	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	98.0	CHEMBL5784	Homo sapiens	Residual Activity	%	98.0
	12240965	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12240966	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	17.0	CHEMBL5784	Homo sapiens	Residual Activity	%	17.0
	12240967	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12240968	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL5784	Homo sapiens	Residual Activity	%	97.0
	12240969	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	62.0	CHEMBL5784	Homo sapiens	Residual Activity	%	62.0
	12240970	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	110.0	CHEMBL5784	Homo sapiens	Residual Activity	%	110.0
	12240971	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	108.0	CHEMBL5784	Homo sapiens	Residual Activity	%	108.0
	12240972	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	122.0	CHEMBL5784	Homo sapiens	Residual Activity	%	122.0
	12240973	CHEMBL2219381	Millipore: Percentage of residual kinase activity of NUAK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	105.0	CHEMBL5784	Homo sapiens	Residual Activity	%	105.0
	12240974	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL5784	Homo sapiens	Residual Activity	%	106.0
	12240975	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	24.0	CHEMBL5784	Homo sapiens	Residual Activity	%	24.0
	12240976	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	127.0	CHEMBL5784	Homo sapiens	Residual Activity	%	127.0
	12240977	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	92.0	CHEMBL5784	Homo sapiens	Residual Activity	%	92.0
	12240978	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	80.0	CHEMBL5784	Homo sapiens	Residual Activity	%	80.0
	12240979	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12240980	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	11.0	CHEMBL5784	Homo sapiens	Residual Activity	%	11.0
	12240981	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	52.0	CHEMBL5784	Homo sapiens	Residual Activity	%	52.0
	12240982	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	78.0	CHEMBL5784	Homo sapiens	Residual Activity	%	78.0
	12240983	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	80.0	CHEMBL5784	Homo sapiens	Residual Activity	%	80.0
	12240984	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	86.0	CHEMBL5784	Homo sapiens	Residual Activity	%	86.0
	12240985	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	66.0	CHEMBL5784	Homo sapiens	Residual Activity	%	66.0
	12240986	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	92.0	CHEMBL5784	Homo sapiens	Residual Activity	%	92.0
	12240987	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	92.0	CHEMBL5784	Homo sapiens	Residual Activity	%	92.0
	12240988	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	13.0	CHEMBL5784	Homo sapiens	Residual Activity	%	13.0
	12240989	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	85.0	CHEMBL5784	Homo sapiens	Residual Activity	%	85.0
	12240990	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	89.0	CHEMBL5784	Homo sapiens	Residual Activity	%	89.0
	12240991	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12240992	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	75.0	CHEMBL5784	Homo sapiens	Residual Activity	%	75.0
	12240993	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	9.0	CHEMBL5784	Homo sapiens	Residual Activity	%	9.0
	12240994	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12240995	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	75.0	CHEMBL5784	Homo sapiens	Residual Activity	%	75.0
	12240996	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12240997	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12240998	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	80.0	CHEMBL5784	Homo sapiens	Residual Activity	%	80.0
	12240999	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	57.0	CHEMBL5784	Homo sapiens	Residual Activity	%	57.0
	12241000	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	20.0	CHEMBL5784	Homo sapiens	Residual Activity	%	20.0
	12241001	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	36.0	CHEMBL5784	Homo sapiens	Residual Activity	%	36.0
	12241002	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	82.0	CHEMBL5784	Homo sapiens	Residual Activity	%	82.0
	12241003	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	38.0	CHEMBL5784	Homo sapiens	Residual Activity	%	38.0
	12241004	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12241005	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	95.0	CHEMBL5784	Homo sapiens	Residual Activity	%	95.0
	12241006	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	80.0	CHEMBL5784	Homo sapiens	Residual Activity	%	80.0
	12241007	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	85.0	CHEMBL5784	Homo sapiens	Residual Activity	%	85.0
	12241008	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	86.0	CHEMBL5784	Homo sapiens	Residual Activity	%	86.0
	12241009	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	101.0	CHEMBL5784	Homo sapiens	Residual Activity	%	101.0
	12241010	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	68.0	CHEMBL5784	Homo sapiens	Residual Activity	%	68.0
	12241011	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL5784	Homo sapiens	Residual Activity	%	96.0
	12241012	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	88.0	CHEMBL5784	Homo sapiens	Residual Activity	%	88.0
	12241013	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	74.0	CHEMBL5784	Homo sapiens	Residual Activity	%	74.0
	12241014	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12241015	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL5784	Homo sapiens	Residual Activity	%	92.0
	12241016	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	6.0	CHEMBL5784	Homo sapiens	Residual Activity	%	6.0
	12241017	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	6.0	CHEMBL5784	Homo sapiens	Residual Activity	%	6.0
	12241018	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	74.0	CHEMBL5784	Homo sapiens	Residual Activity	%	74.0
	12241019	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12241020	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	95.0	CHEMBL5784	Homo sapiens	Residual Activity	%	95.0
	12241021	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	19.0	CHEMBL5784	Homo sapiens	Residual Activity	%	19.0
	12241022	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	93.0	CHEMBL5784	Homo sapiens	Residual Activity	%	93.0
	12241023	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL5784	Homo sapiens	Residual Activity	%	99.0
	12241024	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12241025	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	67.0	CHEMBL5784	Homo sapiens	Residual Activity	%	67.0
	12241026	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	5.0	CHEMBL5784	Homo sapiens	Residual Activity	%	5.0
	12241027	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	71.0	CHEMBL5784	Homo sapiens	Residual Activity	%	71.0
	12241028	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	100.0	CHEMBL5784	Homo sapiens	Residual Activity	%	100.0
	12241029	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	108.0	CHEMBL5784	Homo sapiens	Residual Activity	%	108.0
	12241030	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	86.0	CHEMBL5784	Homo sapiens	Residual Activity	%	86.0
	12241031	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	120.0	CHEMBL5784	Homo sapiens	Residual Activity	%	120.0
	12241032	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	65.0	CHEMBL5784	Homo sapiens	Residual Activity	%	65.0
	12241033	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL5784	Homo sapiens	Residual Activity	%	82.0
	12241034	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	50.0	CHEMBL5784	Homo sapiens	Residual Activity	%	50.0
	12241035	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	7.0	CHEMBL5784	Homo sapiens	Residual Activity	%	7.0
	12241036	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL5784	Homo sapiens	Residual Activity	%	96.0
	12241037	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12241038	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12241039	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	80.0	CHEMBL5784	Homo sapiens	Residual Activity	%	80.0
	12241040	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241041	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	82.0	CHEMBL5784	Homo sapiens	Residual Activity	%	82.0
	12241042	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	81.0	CHEMBL5784	Homo sapiens	Residual Activity	%	81.0
	12241043	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	79.0	CHEMBL5784	Homo sapiens	Residual Activity	%	79.0
	12241044	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241045	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	41.0	CHEMBL5784	Homo sapiens	Residual Activity	%	41.0
	12241046	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	11.0	CHEMBL5784	Homo sapiens	Residual Activity	%	11.0
	12241047	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12241048	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	27.0	CHEMBL5784	Homo sapiens	Residual Activity	%	27.0
	12241049	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	27.0	CHEMBL5784	Homo sapiens	Residual Activity	%	27.0
	12241050	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	87.0	CHEMBL5784	Homo sapiens	Residual Activity	%	87.0
	12241051	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	6.0	CHEMBL5784	Homo sapiens	Residual Activity	%	6.0
	12241052	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	77.0	CHEMBL5784	Homo sapiens	Residual Activity	%	77.0
	12241053	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL5784	Homo sapiens	Residual Activity	%	1.0
	12241054	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241055	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	7.0	CHEMBL5784	Homo sapiens	Residual Activity	%	7.0
	12241056	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	45.0	CHEMBL5784	Homo sapiens	Residual Activity	%	45.0
	12241057	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12241058	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	3.0	CHEMBL5784	Homo sapiens	Residual Activity	%	3.0
	12241059	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	78.0	CHEMBL5784	Homo sapiens	Residual Activity	%	78.0
	12241060	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	60.0	CHEMBL5784	Homo sapiens	Residual Activity	%	60.0
	12241061	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241062	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	83.0	CHEMBL5784	Homo sapiens	Residual Activity	%	83.0
	12241063	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	7.0	CHEMBL5784	Homo sapiens	Residual Activity	%	7.0
	12241064	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12241065	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	79.0	CHEMBL5784	Homo sapiens	Residual Activity	%	79.0
	12241066	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	-1.0	CHEMBL5784	Homo sapiens	Residual Activity	%	-1.0
	12241067	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL5784	Homo sapiens	Residual Activity	%	93.0
	12241068	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	88.0	CHEMBL5784	Homo sapiens	Residual Activity	%	88.0
	12241069	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	52.0	CHEMBL5784	Homo sapiens	Residual Activity	%	52.0
	12241070	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	86.0	CHEMBL5784	Homo sapiens	Residual Activity	%	86.0
	12241071	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241072	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	89.0	CHEMBL5784	Homo sapiens	Residual Activity	%	89.0
	12241073	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	45.0	CHEMBL5784	Homo sapiens	Residual Activity	%	45.0
	12241074	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	13.0	CHEMBL5784	Homo sapiens	Residual Activity	%	13.0
	12241075	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL5784	Homo sapiens	Residual Activity	%	1.0
	12241076	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	93.0	CHEMBL5784	Homo sapiens	Residual Activity	%	93.0
	12241077	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	48.0	CHEMBL5784	Homo sapiens	Residual Activity	%	48.0
	12241078	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	9.0	CHEMBL5784	Homo sapiens	Residual Activity	%	9.0
	12241079	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	83.0	CHEMBL5784	Homo sapiens	Residual Activity	%	83.0
	12241080	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	85.0	CHEMBL5784	Homo sapiens	Residual Activity	%	85.0
	12241081	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	83.0	CHEMBL5784	Homo sapiens	Residual Activity	%	83.0
	12241082	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12241083	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	2.0	CHEMBL5784	Homo sapiens	Residual Activity	%	2.0
	12241084	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	89.0	CHEMBL5784	Homo sapiens	Residual Activity	%	89.0
	12241085	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	88.0	CHEMBL5784	Homo sapiens	Residual Activity	%	88.0
	12241086	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	8.0	CHEMBL5784	Homo sapiens	Residual Activity	%	8.0
	12241087	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	46.0	CHEMBL5784	Homo sapiens	Residual Activity	%	46.0
	12241088	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	85.0	CHEMBL5784	Homo sapiens	Residual Activity	%	85.0
	12241089	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241090	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	13.0	CHEMBL5784	Homo sapiens	Residual Activity	%	13.0
	12241091	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	75.0	CHEMBL5784	Homo sapiens	Residual Activity	%	75.0
	12241092	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	77.0	CHEMBL5784	Homo sapiens	Residual Activity	%	77.0
	12241093	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12241094	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	16.0	CHEMBL5784	Homo sapiens	Residual Activity	%	16.0
	12241095	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	10.0	CHEMBL5784	Homo sapiens	Residual Activity	%	10.0
	12241096	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	29.0	CHEMBL5784	Homo sapiens	Residual Activity	%	29.0
	12241097	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	60.0	CHEMBL5784	Homo sapiens	Residual Activity	%	60.0
	12241098	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	5.0	CHEMBL5784	Homo sapiens	Residual Activity	%	5.0
	12241099	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12241100	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	33.0	CHEMBL5784	Homo sapiens	Residual Activity	%	33.0
	12241101	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12241102	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	22.0	CHEMBL5784	Homo sapiens	Residual Activity	%	22.0
	12241103	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL5784	Homo sapiens	Residual Activity	%	0.0
	12241104	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	77.0	CHEMBL5784	Homo sapiens	Residual Activity	%	77.0
	12241105	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241106	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	17.0	CHEMBL5784	Homo sapiens	Residual Activity	%	17.0
	12241107	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	84.0	CHEMBL5784	Homo sapiens	Residual Activity	%	84.0
	12241108	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	7.0	CHEMBL5784	Homo sapiens	Residual Activity	%	7.0
	12241109	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	13.0	CHEMBL5784	Homo sapiens	Residual Activity	%	13.0
	12241110	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	40.0	CHEMBL5784	Homo sapiens	Residual Activity	%	40.0
	12241111	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	4.0	CHEMBL5784	Homo sapiens	Residual Activity	%	4.0
	12241112	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	18.0	CHEMBL5784	Homo sapiens	Residual Activity	%	18.0
	12241113	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	31.0	CHEMBL5784	Homo sapiens	Residual Activity	%	31.0
	12241114	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	62.0	CHEMBL5784	Homo sapiens	Residual Activity	%	62.0
	12241115	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	11.0	CHEMBL5784	Homo sapiens	Residual Activity	%	11.0
	12241116	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	28.0	CHEMBL5784	Homo sapiens	Residual Activity	%	28.0
	12241117	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	13.0	CHEMBL5784	Homo sapiens	Residual Activity	%	13.0
	12241118	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	91.0	CHEMBL5784	Homo sapiens	Residual Activity	%	91.0
	12241119	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	72.0	CHEMBL5784	Homo sapiens	Residual Activity	%	72.0
	12241120	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	19.0	CHEMBL5784	Homo sapiens	Residual Activity	%	19.0
	12241121	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	82.0	CHEMBL5784	Homo sapiens	Residual Activity	%	82.0
	12241122	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	90.0	CHEMBL5784	Homo sapiens	Residual Activity	%	90.0
	12241123	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241124	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	8.0	CHEMBL5784	Homo sapiens	Residual Activity	%	8.0
	12241125	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	94.0	CHEMBL5784	Homo sapiens	Residual Activity	%	94.0
	12241126	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	102.0	CHEMBL5784	Homo sapiens	Residual Activity	%	102.0
	12241127	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	50.0	CHEMBL5784	Homo sapiens	Residual Activity	%	50.0
	12241128	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL5784	Homo sapiens	Residual Activity	%	92.0
	12241129	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	23.0	CHEMBL5784	Homo sapiens	Residual Activity	%	23.0
	12241130	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	93.0	CHEMBL5784	Homo sapiens	Residual Activity	%	93.0
	12241131	CHEMBL2219382	Millipore: Percentage of residual kinase activity of NUAK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-1.0	CHEMBL5784	Homo sapiens	Residual Activity	%	-1.0
	12671318	CHEMBL2344169	Inhibition of ARK5 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	1700.0	CHEMBL5784	Homo sapiens	IC50	uM	1.7
	12671319	CHEMBL2344169	Inhibition of ARK5 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	1800.0	CHEMBL5784	Homo sapiens	IC50	uM	1.8
	12671320	CHEMBL2344169	Inhibition of ARK5 (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	3200.0	CHEMBL5784	Homo sapiens	IC50	uM	3.2
	12672957	CHEMBL2339295	Inhibition of recombinant NUAK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	7.0	CHEMBL5784	Homo sapiens	Activity	%	7.0
	12672958	CHEMBL2339295	Inhibition of recombinant NUAK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	8.0	CHEMBL5784	Homo sapiens	Activity	%	8.0
	12727621	CHEMBL2352549	Inhibition of ARK5 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	94.0	CHEMBL5784	Homo sapiens	Activity	%	94.0
	12730934	CHEMBL2350107	Inhibition of ARK5 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	84.0	CHEMBL5784	Homo sapiens	Activity	%	84.0
Active	13300198	CHEMBL2384445	Inhibition of human NUAK1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(N4CCC(N)CC4)nn23)cn1		CHEMBL2380696		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Active	13300199	CHEMBL2384445	Inhibition of human NUAK1 at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	13374416	CHEMBL2406549	Inhibition of NUAK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1	Outside typical range	CHEMBL2402081	=	Inhibition	%	-14.0	CHEMBL5784	Homo sapiens	INH	%	-14.0
	13439896	CHEMBL2428325	Competitive binding affinity to ARK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	13448461	CHEMBL2428325	Competitive binding affinity to ARK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	74.0	CHEMBL5784	Homo sapiens	INH	%	74.0
	13451716	CHEMBL2428325	Competitive binding affinity to ARK5 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	72.0	CHEMBL5784	Homo sapiens	INH	%	72.0
	13476404	CHEMBL2439128	Inhibition of human wild type ARK5 at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	>	Inhibition	%	90.0	CHEMBL5784	Homo sapiens	INH	%	90.0
	13481566	CHEMBL2439293	Inhibition of human ARK5	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2=O		CHEMBL2436172	=	IC50	nM	570.0	CHEMBL5784	Homo sapiens	IC50	uM	0.57
Active	13488448	CHEMBL2439435	Inhibition of human NUAK1 at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Active	13488449	CHEMBL2439435	Inhibition of human NUAK1 at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Active	13488450	CHEMBL2439435	Inhibition of human NUAK1 at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	13872207	CHEMBL3102394	Inhibition of human ARK5 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	81.0	CHEMBL5784	Homo sapiens	Activity	%	81.0
	13878435	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	5090.0	CHEMBL5784	Homo sapiens	IC50	uM	5.09
	13878436	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.0	CHEMBL5784	Homo sapiens	IC50	uM	0.008
	13878437	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	=	IC50	nM	3770.0	CHEMBL5784	Homo sapiens	IC50	uM	3.77
	13878438	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	=	IC50	nM	10000.0	CHEMBL5784	Homo sapiens	IC50	uM	10.0
	13878439	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	>	IC50	nM	30000.0	CHEMBL5784	Homo sapiens	IC50	uM	30.0
	13878440	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	=	IC50	nM	29800.0	CHEMBL5784	Homo sapiens	IC50	uM	29.8
	13878441	CHEMBL3108328	Inhibition of ARK5 (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	=	IC50	nM	2510.0	CHEMBL5784	Homo sapiens	IC50	uM	2.51
	13897472	CHEMBL3111647	Inhibition of recombinant ARK5 (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	=	IC50	nM	29400.0	CHEMBL5784	Homo sapiens	IC50	uM	29.4
	13897473	CHEMBL3111647	Inhibition of recombinant ARK5 (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	13897474	CHEMBL3111647	Inhibition of recombinant ARK5 (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	13917430	CHEMBL3117359	Inhibition of ARK5 (unknown origin)	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	IC50	nM	5000.0	CHEMBL5784	Homo sapiens	IC50	nM	5000.0
	13917506	CHEMBL3117359	Inhibition of ARK5 (unknown origin)	B	CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL3115681	=	IC50	nM	4.95	CHEMBL5784	Homo sapiens	IC50	nM	4.95
	13954558	CHEMBL3130939	Inhibition of human ARK5 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	76.0	CHEMBL5784	Homo sapiens	Activity	%	76.0
	13954732	CHEMBL3130939	Inhibition of human ARK5 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	79.0	CHEMBL5784	Homo sapiens	Activity	%	79.0
	13954752	CHEMBL3130939	Inhibition of human ARK5 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	68.0	CHEMBL5784	Homo sapiens	Activity	%	68.0
	14582436	CHEMBL3240219	Inhibition of human ARK5 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	109.0	CHEMBL5784	Homo sapiens	Activity	%	109.0
	14659153	CHEMBL3269728	Inhibition of NUAK1 (unknown origin) at 25 uM	B	CC(=O)c1cccc(NC(=O)c2sc3nc4cc5c(cc4cc3c2N)OCCO5)c1		CHEMBL3261343	=	Inhibition	%	49.0	CHEMBL5784	Homo sapiens	INH	%	49.0
	15055293	CHEMBL3380461	Inhibition of human recombinant ARK5	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	15056474	CHEMBL3363362	Inhibition of Nuak1 (unknown origin) by Off-chip Mobility Shift Assay	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	7.97	CHEMBL5784	Homo sapiens	IC50	nM	7.97
	15058845	CHEMBL3371399	Inhibition of ARK5 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	41.0	CHEMBL5784	Homo sapiens	Activity	%	41.0
	15072439	CHEMBL3388054	Inhibition of NUAK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	15251888	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	28.0	CHEMBL5784	Homo sapiens	Activity	%	28.0
	15251909	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	14.0	CHEMBL5784	Homo sapiens	Activity	%	14.0
	15252011	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	65.0	CHEMBL5784	Homo sapiens	Activity	%	65.0
	15252656	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	65.0	CHEMBL5784	Homo sapiens	Activity	%	65.0
	15252758	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	78.0	CHEMBL5784	Homo sapiens	Activity	%	78.0
	15252860	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	81.0	CHEMBL5784	Homo sapiens	Activity	%	81.0
	15253534	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	35.0	CHEMBL5784	Homo sapiens	Activity	%	35.0
	15253636	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	76.0	CHEMBL5784	Homo sapiens	Activity	%	76.0
	15253738	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	78.0	CHEMBL5784	Homo sapiens	Activity	%	78.0
	15253805	CHEMBL3429889	Inhibition of human Ark5	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	>	IC50	nM	10000.0	CHEMBL5784	Homo sapiens	IC50	uM	10.0
	15254404	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	56.0	CHEMBL5784	Homo sapiens	Activity	%	56.0
	15254506	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	39.0	CHEMBL5784	Homo sapiens	Activity	%	39.0
	15254608	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	31.0	CHEMBL5784	Homo sapiens	Activity	%	31.0
	15255299	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	41.0	CHEMBL5784	Homo sapiens	Activity	%	41.0
	15255401	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	57.0	CHEMBL5784	Homo sapiens	Activity	%	57.0
	15255504	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	53.0	CHEMBL5784	Homo sapiens	Activity	%	53.0
	15256235	CHEMBL3427814	Inhibition of NUAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	37.0	CHEMBL5784	Homo sapiens	Activity	%	37.0
	15667030	CHEMBL3603307	Inhibition of ARK5 (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	Activity	%	9.6	CHEMBL5784	Homo sapiens	Activity	%	9.6
	15756108	CHEMBL3631726	Inhibition of ARK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	41.08	CHEMBL5784	Homo sapiens	INH	%	41.08
	15757703	CHEMBL3631726	Inhibition of ARK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-0.15	CHEMBL5784	Homo sapiens	INH	%	-0.15
	15757991	CHEMBL3631726	Inhibition of ARK5 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	7.6	CHEMBL5784	Homo sapiens	INH	%	7.6
	16425390	CHEMBL3751063	Inhibition of ARK5 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.8	CHEMBL5784	Homo sapiens	INH	%	-3.8
	16431731	CHEMBL3748623	Inhibition of human ARK5 using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5784	Homo sapiens	IC50	uM	10.0
	16450760	CHEMBL3762146	Inhibition of ARK5 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	11.6	CHEMBL5784	Homo sapiens	INH	%	11.6
	16495334	CHEMBL3776647	Inhibition of N-terminal His6-tagged recombinant human ARK5 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-17.0	CHEMBL5784	Homo sapiens	Activity	%	-17.0
	16508103	CHEMBL3776647	Inhibition of N-terminal His6-tagged recombinant human ARK5 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL5784	Homo sapiens	Activity	%	3.0
	16509080	CHEMBL3776647	Inhibition of N-terminal His6-tagged recombinant human ARK5 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-20.0	CHEMBL5784	Homo sapiens	Activity	%	-20.0
	16515250	CHEMBL3784252	Inhibition of NUAK1 (unknown origin)	B	N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1		CHEMBL3780091	=	IC50	nM	2.0	CHEMBL5784	Homo sapiens	IC50	nM	2.0
	16534409	CHEMBL3789291	Inhibition of human ARK5 at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	96.0	CHEMBL5784	Homo sapiens	INH	%	96.0
	16593694	CHEMBL3811004	Inhibition of NUAK1 (unknown origin) at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL5784	Homo sapiens	INH	%	40.0
	16612623	CHEMBL3815493	Inhibition of human NUAK1 (2 to 660 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-31.0	CHEMBL5784	Homo sapiens	Activity	%	-31.0
	16613770	CHEMBL3817206	Inhibition of human ARK5 at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	0.0	CHEMBL5784	Homo sapiens	INH	%	0.0
	16654133	CHEMBL3829189	Inhibition of human NUAK1 (2 to 660 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	52.0	CHEMBL5784	Homo sapiens	Activity	%	52.0
	16804184	CHEMBL3869775	Inhibition of human recombinant full length His-tagged NUAK1 (510 to 825 residues) expressed in baculovirus expression system at 200 nM by adapta assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	63.0	CHEMBL5784	Homo sapiens	INH	%	63.0
	16837379	CHEMBL3876037	Inhibition of human recombinant full length His-tagged NUAK1 expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	5.0	CHEMBL5784	Homo sapiens	IC50	nM	5.0
	18114479	CHEMBL4025015	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	18135852	CHEMBL4029825	Inhibition of full length recombinant human N-terminal GST-tagged NUAK1 expressed in baculovirus infected Sf9 insect cells using CHK peptide as substrate measured after 30 mins in presence of [gamma32P]ATP by liquid scintillation counting method	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4ccc(C(=O)O)cc43)c3ccccc3)cc2)CC1		CHEMBL4089284	=	Ki	nM	8.6	CHEMBL5784	Homo sapiens	Ki	nM	8.6
	18135861	CHEMBL4029825	Inhibition of full length recombinant human N-terminal GST-tagged NUAK1 expressed in baculovirus infected Sf9 insect cells using CHK peptide as substrate measured after 30 mins in presence of [gamma32P]ATP by liquid scintillation counting method	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4ccccc43)c3ccccc3)cc2)CC1		CHEMBL1908392	=	Ki	nM	1.7	CHEMBL5784	Homo sapiens	Ki	nM	1.7
	18135916	CHEMBL4029825	Inhibition of full length recombinant human N-terminal GST-tagged NUAK1 expressed in baculovirus infected Sf9 insect cells using CHK peptide as substrate measured after 30 mins in presence of [gamma32P]ATP by liquid scintillation counting method	B	COC(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)C(=O)N2		CHEMBL4062168	=	Ki	nM	11.0	CHEMBL5784	Homo sapiens	Ki	nM	11.0
	18153257	CHEMBL4034432	Inhibition of NuaK1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-22.5	CHEMBL5784	Homo sapiens	INH	%	-22.5
	18203405	CHEMBL4043826	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	18232178	CHEMBL4050328	Inhibition of human NUAK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	75.0	CHEMBL5784	Homo sapiens	Activity	%	75.0
	18253211	CHEMBL4054889	Inhibition of human NUAK1 (25 to I332 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	2.0	CHEMBL5784	Homo sapiens	Activity	%	2.0
	18253212	CHEMBL4054889	Inhibition of human NUAK1 (25 to I332 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	6.0	CHEMBL5784	Homo sapiens	Activity	%	6.0
	18265903	CHEMBL4057353	Inhibition of NuaK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.0	CHEMBL5784	Homo sapiens	INH	%	13.0
	18266097	CHEMBL4057547	Inhibition of NuaK1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	5.7	CHEMBL5784	Homo sapiens	INH	%	5.7
	18282050	CHEMBL4120005	Inhibition of recombinant full length His-tagged human ARK5 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	30.1	CHEMBL5784	Homo sapiens	INH	%	30.1
	18282369	CHEMBL4120005	Inhibition of recombinant full length His-tagged human ARK5 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	29.1	CHEMBL5784	Homo sapiens	INH	%	29.1
	18282786	CHEMBL4120371	Inhibition of NuaK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.0	CHEMBL5784	Homo sapiens	INH	%	13.0
	18283013	CHEMBL4120598	Inhibition of NuaK1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	2.3	CHEMBL5784	Homo sapiens	INH	%	2.3
	18283237	CHEMBL4120822	Inhibition of NuaK1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.7	CHEMBL5784	Homo sapiens	INH	%	0.7
	18378351	CHEMBL4145196	Inhibition of recombinant human full length His-tagged NUAK1 expressed in baculovirus at 1 uM	B	CC[C@@H](C)Nc1nc(Nc2cc(N3C[C@@H]4C[C@H]3CN4C)cnc2F)ncc1C		CHEMBL4169221	=	Inhibition	%	71.0	CHEMBL5784	Homo sapiens	INH	%	71.0
	18440081	CHEMBL4156905	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	92.0	CHEMBL5784	Homo sapiens	Activity	%	92.0
	18449924	CHEMBL4178158	Inhibition of human NUAK1 (2 to 660 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	86.0	CHEMBL5784	Homo sapiens	Activity	%	86.0
	18484521	CHEMBL4185684	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	85.0	CHEMBL5784	Homo sapiens	Activity	%	85.0
	18485100	CHEMBL4185684	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	84.0	CHEMBL5784	Homo sapiens	Activity	%	84.0
Active	18499348	CHEMBL4188990	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system at 1 uM using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	18507897	CHEMBL4190869	Inhibition of recombinant human ARK5 (2 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	15.0	CHEMBL5784	Homo sapiens	INH	%	15.0
	18653765	CHEMBL4230021	Inhibition of ARK5 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	14.0	CHEMBL5784	Homo sapiens	INH	%	14.0
	18653766	CHEMBL4230021	Inhibition of ARK5 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	1.0	CHEMBL5784	Homo sapiens	INH	%	1.0
	18655636	CHEMBL4230584	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	93.0	CHEMBL5784	Homo sapiens	Activity	%	93.0
	18737240	CHEMBL4261282	Binding affinity to DNA-tagged recombinant human ARK5 (25 to 332 residues) expressed in bacterial expression system by KINOMEscan assay	B	COc1cc2c(=O)n(CC3CCCCC3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4284499	=	Kd	nM	42.0	CHEMBL5784	Homo sapiens	Kd	nM	42.0
Not Determined	18737241	CHEMBL4261282	Binding affinity to DNA-tagged recombinant human ARK5 (25 to 332 residues) expressed in bacterial expression system by KINOMEscan assay	B	COc1cc2c(=O)n([C@@H]3CCCN(C(=O)CC#N)C3)c3c4cc[nH]c4ncc3c2cc1OC		CHEMBL4290597		Kd			CHEMBL5784	Homo sapiens	Kd		
	18751070	CHEMBL4263735	Inhibition of ARK5 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	94.0	CHEMBL5784	Homo sapiens	INH	%	94.0
	18751730	CHEMBL4264173	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	18761499	CHEMBL4266524	Inhibition of recombinant human N-terminal His6-tagged ARK5 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	24.0	CHEMBL5784	Homo sapiens	INH	%	24.0
	18761743	CHEMBL4266524	Inhibition of recombinant human N-terminal His6-tagged ARK5 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	12.0	CHEMBL5784	Homo sapiens	INH	%	12.0
	18761906	CHEMBL4266524	Inhibition of recombinant human N-terminal His6-tagged ARK5 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-2.0	CHEMBL5784	Homo sapiens	INH	%	-2.0
	18764632	CHEMBL4267113	Inhibition of human NUAK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL5784	Homo sapiens	INH	%	70.0
	18764633	CHEMBL4267113	Inhibition of human NUAK1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL5784	Homo sapiens	INH	%	70.0
	18764634	CHEMBL4267113	Inhibition of human NUAK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL5784	Homo sapiens	INH	%	70.0
	18812589	CHEMBL4276361	Inhibition of N-terminal GST-tagged full length human NuaK1 (1 to 661 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	>	IC50	nM	100.0	CHEMBL5784	Homo sapiens	IC50	nM	100.0
	18812736	CHEMBL4276361	Inhibition of N-terminal GST-tagged full length human NuaK1 (1 to 661 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	7.97	CHEMBL5784	Homo sapiens	IC50	nM	7.97
	18857844	CHEMBL4307690	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	94.0	CHEMBL5784	Homo sapiens	Activity	%	94.0
	18892753	CHEMBL4314649	Inhibition of recombinant human ARK5 (2 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	107.5	CHEMBL5784	Homo sapiens	Activity	%	107.5
	18919496	CHEMBL4322853	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged NUAK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	15.0	CHEMBL5784	Homo sapiens	Kd	nM	15.0
	18919684	CHEMBL4322853	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged NUAK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	13.0	CHEMBL5784	Homo sapiens	Kd	nM	13.0
	18924788	CHEMBL4324299	Inhibition of recombinant full length human His-tagged ARK5 expressed in baculovirus expression system	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864	=	IC50	nM	400.0	CHEMBL5784	Homo sapiens	IC50	uM	0.4
	18924815	CHEMBL4324328	Inhibition of recombinant full length human His-tagged ARK5 expressed in baculovirus expression system at 1 uM relative to control	B	COC[C@H]1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1ccc(F)c(F)c1		CHEMBL4482864	=	Inhibition	%	80.0	CHEMBL5784	Homo sapiens	INH	%	80.0
	18937713	CHEMBL4327586	Inhibition of human ARK5 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	87.87	CHEMBL5784	Homo sapiens	Activity	%	87.87
	18937714	CHEMBL4327586	Inhibition of human ARK5 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.54	CHEMBL5784	Homo sapiens	Activity	%	100.54
	18938427	CHEMBL4327947	Inhibition of human ARK5 assessed as residual activity at 100 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5784	Homo sapiens	Activity	%	65.0
	18938799	CHEMBL4328311	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.41	CHEMBL5784	Homo sapiens	IC50	10'-9M	1.41
	18958681	CHEMBL4333282	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	82.0	CHEMBL5784	Homo sapiens	Activity	%	82.0
	18964070	CHEMBL4334969	Inhibition of recombinant human ARK5 (2 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	99.0	CHEMBL5784	Homo sapiens	Activity	%	99.0
	18964071	CHEMBL4334969	Inhibition of recombinant human ARK5 (2 to end residues) assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	79.0	CHEMBL5784	Homo sapiens	Activity	%	79.0
	18971787	CHEMBL4336797	Inhibition of recombinant human ARK5 (2 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	73.0	CHEMBL5784	Homo sapiens	Activity	%	73.0
	18976061	CHEMBL4338209	Inhibition of NUAK1 (unknown origin) by assessed as residual enzyme activity at 1 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	46.0	CHEMBL5784	Homo sapiens	Activity	%	46.0
Not Active	19039895	CHEMBL4351746	Inhibition of recombinant human ARK5 (2 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
Active	19041012	CHEMBL4352273	Inhibition of human ARK5 at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	19059461	CHEMBL4357762	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	19090034	CHEMBL4365608	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5784	Homo sapiens	Activity	%	100.0
	19091815	CHEMBL4366289	Inhibition of human ARK5 at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	0.26	CHEMBL5784	Homo sapiens	INH	%	0.26
	19118095	CHEMBL4372264	Inhibition of ARK5 (unknown origin) at 1 uM by radioactivity-based assay relative to control	B	COCCN1CCN(c2ccc(OCc3ccccc3)c(C(=O)Nc3ccnnc3)c2)CC1		CHEMBL4448579	=	Inhibition	%	53.0	CHEMBL5784	Homo sapiens	INH	%	53.0
	19118517	CHEMBL4372361	Inhibition of recombinant human N-terminal His6-tagged ARK5 (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using CHKtide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	20.0	CHEMBL5784	Homo sapiens	INH	%	20.0
	19144616	CHEMBL4377632	Inhibition of recombinant human ARK5 (2 to end residues) at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	79.0	CHEMBL5784	Homo sapiens	INH	%	79.0
	19146823	CHEMBL4378969	Inhibition of recombinant human ARK5 (2 to end residues) at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	10.0	CHEMBL5784	Homo sapiens	INH	%	10.0
	19147747	CHEMBL4379143	Inhibition of human recombinant ARK5 (2 to end residues) using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5784	Homo sapiens	IC50	uM	10.0
	19159289	CHEMBL4382393	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	8.1	CHEMBL5784	Homo sapiens	Activity	%	8.1
	19180959	CHEMBL4387169	Inhibition of recombinant full length human His-tagged ARK5 expressed in baculovirus expression system at 0.1 uM using CHKtide peptide as substrate incubated for 60 mins by Adapta assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	22.7	CHEMBL5784	Homo sapiens	INH	%	22.7
	19181185	CHEMBL4387169	Inhibition of recombinant full length human His-tagged ARK5 expressed in baculovirus expression system at 0.1 uM using CHKtide peptide as substrate incubated for 60 mins by Adapta assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	92.0	CHEMBL5784	Homo sapiens	INH	%	92.0
	19191236	CHEMBL4389589	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	45.0	CHEMBL5784	Homo sapiens	INH	%	45.0
	19191718	CHEMBL4389112	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	25.0	CHEMBL5784	Homo sapiens	INH	%	25.0
	19200007	CHEMBL4391215	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	0.85	CHEMBL5784	Homo sapiens	Activity	%	0.85
	19266312	CHEMBL4405262	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	19275931	CHEMBL4407934	Inhibition of recombinant human ARK5 (2 to end residues) at 1 uM using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	69.0	CHEMBL5784	Homo sapiens	INH	%	69.0
	19292315	CHEMBL4411566	Inhibition of N-terminal GST tagged full length human Nuak1 (1 to 661 end residues) expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	60.0	CHEMBL5784	Homo sapiens	INH	%	60.0
	19294330	CHEMBL4412087	Inhibition of human ARK5 assessed as enzyme activity at 30 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	O=C1C=CC2(C=C1)OCC(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)N2c1ccccc1		CHEMBL4476753	=	Activity	%	70.7	CHEMBL5784	Homo sapiens	Activity	%	70.7
	19294346	CHEMBL4412103	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.31	CHEMBL5784	Homo sapiens	IC50	10'-9M	1.31
	19476611	CHEMBL4479759	Inhibition of full-length recombinant human His-tagged NUAK1 expressed in baculovirus expression system by Adapta assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	15.0	CHEMBL5784	Homo sapiens	IC50	nM	15.0
	19476711	CHEMBL4479759	Inhibition of full-length recombinant human His-tagged NUAK1 expressed in baculovirus expression system by Adapta assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	19.0	CHEMBL5784	Homo sapiens	IC50	nM	19.0
	19476811	CHEMBL4479759	Inhibition of full-length recombinant human His-tagged NUAK1 expressed in baculovirus expression system by Adapta assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	4.2	CHEMBL5784	Homo sapiens	IC50	nM	4.2
	19476911	CHEMBL4479759	Inhibition of full-length recombinant human His-tagged NUAK1 expressed in baculovirus expression system by Adapta assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	200.0	CHEMBL5784	Homo sapiens	IC50	nM	200.0
	20600610	CHEMBL4603562	Inhibition of recombinant full length His-tagged human NUAK1 expressed in baculovirus expression system using CHKtide as substrate after 1 hr in presence of ATP by Adapta assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5784	Homo sapiens	IC50	uM	100.0
	22392006	CHEMBL4667101	Inhibition of recombinant human His-tagged full length ARK5 expressed in baculovirus expression system using CHKtide as substrate at 10 uM incubated for 60 mins by Adapta assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	8.5	CHEMBL5784	Homo sapiens	INH	%	8.5
	22423124	CHEMBL4674137	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL5784	Homo sapiens	INH	%	80.0
	22423827	CHEMBL4674489	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	16.52	CHEMBL5784	Homo sapiens	Activity	%	16.52
	22423828	CHEMBL4674489	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	3.28	CHEMBL5784	Homo sapiens	Activity	%	3.28
	22752657	CHEMBL4700134	Inhibition of human NAUK1 by kinase-profiling analysis	B	C#Cc1nc(Nc2cccc(CC(N)=O)c2)nc2[nH]cnc12		CHEMBL4786783	=	IC50	nM	120.0	CHEMBL5784	Homo sapiens	IC50	uM	0.12
	22820424	CHEMBL4716214	Inhibition of N-terminal His6-tagged human recombinant ARK5 (2 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	102.0	CHEMBL5784	Homo sapiens	Activity	%	102.0
	22820425	CHEMBL4716214	Inhibition of N-terminal His6-tagged human recombinant ARK5 (2 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	0.0	CHEMBL5784	Homo sapiens	Activity	%	0.0
	22843847	CHEMBL4720833	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.35	CHEMBL5784	Homo sapiens	IC50	10^-9M	1.35
	22844139	CHEMBL4721125	Inhibition of human ARK5 assessed as residual activity using KKKVSRSGLYRSPSMPENLNRPR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.57	CHEMBL5784	Homo sapiens	Activity	%	95.57
	22844621	CHEMBL4721296	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	47.64	CHEMBL5784	Homo sapiens	Activity	%	47.64
	22952755	CHEMBL4766692	Inhibition of recombinant human ARK5 (2 to end residues) assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	92.0	CHEMBL5784	Homo sapiens	Activity	%	92.0
	22979765	CHEMBL4772647	Binding affinity to wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	140.0	CHEMBL5784	Homo sapiens	Kd	nM	140.0
	22979799	CHEMBL4772681	Inhibition of wild-type human partial length ARK5 (E25 to I332 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL5784	Homo sapiens	Activity	%	90.0
	22990678	CHEMBL4775120	Inhibition of human NUAK1 expressed in baculovirus expression system at 1 uM relative to control	B	CC(C)n1c(=O)n(C)c2cnc3cc(F)c(-c4ccc(OCCCN5CCCCC5)nc4)cc3c21		CHEMBL4594429	>=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	23120800	CHEMBL4804450	Inhibition of NuaK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	71700.0	CHEMBL5784	Homo sapiens	IC50	uM	71.7
	23120801	CHEMBL4804450	Inhibition of NuaK1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	5600.0	CHEMBL5784	Homo sapiens	IC50	uM	5.6
	23120802	CHEMBL4804450	Inhibition of NuaK1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	40800.0	CHEMBL5784	Homo sapiens	IC50	uM	40.8
	23120803	CHEMBL4804450	Inhibition of NuaK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	68800.0	CHEMBL5784	Homo sapiens	IC50	uM	68.8
	23120804	CHEMBL4804450	Inhibition of NuaK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	61500.0	CHEMBL5784	Homo sapiens	IC50	uM	61.5
	23120805	CHEMBL4804450	Inhibition of NuaK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	IC50	nM	90000.0	CHEMBL5784	Homo sapiens	IC50	uM	90.0
	23121838	CHEMBL4804632	Inhibition of NuaK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	<=	Inhibition	%	90.0	CHEMBL5784	Homo sapiens	INH	%	90.0
	23121839	CHEMBL4804632	Inhibition of NuaK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	23121840	CHEMBL4804632	Inhibition of NuaK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	35.0	CHEMBL5784	Homo sapiens	INH	%	35.0
	23121841	CHEMBL4804632	Inhibition of NuaK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	23121842	CHEMBL4804632	Inhibition of NuaK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL5784	Homo sapiens	INH	%	50.0
	23121843	CHEMBL4804632	Inhibition of NuaK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL5784	Homo sapiens	INH	%	90.0
	23122447	CHEMBL4804798	Inhibition of human ARK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL5784	Homo sapiens	Activity	%	89.0
	23123142	CHEMBL4805386	Inhibition of human ARK5 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	98.0	CHEMBL5784	Homo sapiens	Activity	%	98.0
	23123745	CHEMBL4805989	Inhibition of DNA-tagged human ARK5 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	85.0	CHEMBL5784	Homo sapiens	Activity	%	85.0
	23124374	CHEMBL4806403	Inhibition of human ARK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	57.0	CHEMBL5784	Homo sapiens	Activity	%	57.0
	23124375	CHEMBL4806403	Inhibition of human ARK5 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	77.0	CHEMBL5784	Homo sapiens	Activity	%	77.0
	23127816	CHEMBL4807747	Inhibition of ARK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5784	Homo sapiens	Activity	%	75.0
	23127817	CHEMBL4807747	Inhibition of ARK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5784	Homo sapiens	Activity	%	75.0
	23127818	CHEMBL4807747	Inhibition of ARK5 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5784	Homo sapiens	Activity	%	75.0
	23172433	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N(C)C)cc3OC)ncc2Cl)c1		CHEMBL4871744	=	Inhibition	%	80.56	CHEMBL5784	Homo sapiens	INH	%	80.56
	23172434	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N(CC)CC)cc3OC)ncc2Cl)c1		CHEMBL4874862	=	Inhibition	%	10.76	CHEMBL5784	Homo sapiens	INH	%	10.76
Not Active	23172435	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCCN(CCC)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)CC)c3)n2)c(OC)c1		CHEMBL4856437		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	23172436	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCC4)cc3OC)ncc2Cl)c1		CHEMBL4853783	=	Inhibition	%	25.77	CHEMBL5784	Homo sapiens	INH	%	25.77
	23172437	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC)ncc2Cl)c1		CHEMBL4855518	=	Inhibition	%	65.57	CHEMBL5784	Homo sapiens	INH	%	65.57
	23172438	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3OC)ncc2Cl)c1		CHEMBL4860972	=	Inhibition	%	13.9	CHEMBL5784	Homo sapiens	INH	%	13.9
	23172439	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCC(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL4847695	=	Inhibition	%	9.2	CHEMBL5784	Homo sapiens	INH	%	9.2
	23172440	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCC(OC)CC4)cc3OC)ncc2Cl)c1		CHEMBL4845937	=	Inhibition	%	5.08	CHEMBL5784	Homo sapiens	INH	%	5.08
	23172441	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N(C)C)cc3)ncc2Cl)c1		CHEMBL4876802	=	Inhibition	%	72.6	CHEMBL5784	Homo sapiens	INH	%	72.6
	23172442	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N(CC)CC)cc3)ncc2Cl)c1		CHEMBL4862892	=	Inhibition	%	54.41	CHEMBL5784	Homo sapiens	INH	%	54.41
	23172443	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCCN(CCC)c1ccc(Nc2ncc(Cl)c(Oc3cccc(NC(=O)CC)c3)n2)cc1		CHEMBL4858921	=	Inhibition	%	9.3	CHEMBL5784	Homo sapiens	INH	%	9.3
Not Active	23172444	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCC4)cc3)ncc2Cl)c1		CHEMBL4866601		Inhibition	%		CHEMBL5784	Homo sapiens	INH		
	23172445	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)ncc2Cl)c1		CHEMBL4851270	=	Inhibition	%	70.92	CHEMBL5784	Homo sapiens	INH	%	70.92
	23172446	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCCC4)cc3)ncc2Cl)c1		CHEMBL4872475	=	Inhibition	%	86.0	CHEMBL5784	Homo sapiens	INH	%	86.0
	23172447	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCC(C)CC4)cc3)ncc2Cl)c1		CHEMBL4857660	=	Inhibition	%	13.4	CHEMBL5784	Homo sapiens	INH	%	13.4
	23172448	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCC(OC)CC4)cc3)ncc2Cl)c1		CHEMBL4850011	=	Inhibition	%	86.53	CHEMBL5784	Homo sapiens	INH	%	86.53
	23172449	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)c1		CHEMBL4853426	=	Inhibition	%	92.9	CHEMBL5784	Homo sapiens	INH	%	92.9
	23172450	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1		CHEMBL4867516	=	Inhibition	%	85.62	CHEMBL5784	Homo sapiens	INH	%	85.62
	23172451	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3Cl)ncc2Cl)c1		CHEMBL4857066	=	Inhibition	%	71.54	CHEMBL5784	Homo sapiens	INH	%	71.54
	23172452	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL4303523	=	Inhibition	%	85.84	CHEMBL5784	Homo sapiens	INH	%	85.84
	23172453	CHEMBL4814707	Inhibition of NUAK1 (unknown origin) at 10 uM using CHKtide as substrate in presence of ATP measured after 60 mins by ADP-Glo assay	B	Cc1nc(Nc2cnn(C3CCNCC3)c2)nc2c1N(C)C(=O)c1cc3ccccc3cc1N2C		CHEMBL4303250	=	Inhibition	%	78.29	CHEMBL5784	Homo sapiens	INH	%	78.29
	23248248	CHEMBL4830425	Inhibition of human ARK5 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL5784	Homo sapiens	Activity	%	20.0
Not Active	23317282	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23317750	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL5784	Homo sapiens	% Control	%	96.0
Not Active	23318424	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	81.0	CHEMBL5784	Homo sapiens	% Control	%	81.0
Not Active	23318900	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23319540	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23320012	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	82.4	CHEMBL5784	Homo sapiens	% Control	%	82.4
Not Active	23320690	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	89.0	CHEMBL5784	Homo sapiens	% Control	%	89.0
Not Active	23321158	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23321788	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	83.0	CHEMBL5784	Homo sapiens	% Control	%	83.0
Not Active	23322256	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	99.0	CHEMBL5784	Homo sapiens	% Control	%	99.0
Not Active	23322945	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	86.0	CHEMBL5784	Homo sapiens	% Control	%	86.0
Not Active	23323413	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	95.0	CHEMBL5784	Homo sapiens	% Control	%	95.0
Not Active	23323951	CHEMBL4880570	ARK5 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	22.0	CHEMBL5784	Homo sapiens	% inhibition	%	22.0
Not Active	23324267	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23324902	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	71.0	CHEMBL5784	Homo sapiens	% Control	%	71.0
Not Active	23325370	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	84.0	CHEMBL5784	Homo sapiens	% Control	%	84.0
Not Active	23326017	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23326485	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	95.0	CHEMBL5784	Homo sapiens	% Control	%	95.0
Not Active	23327185	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	83.0	CHEMBL5784	Homo sapiens	% Control	%	83.0
Not Active	23327653	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	88.0	CHEMBL5784	Homo sapiens	% Control	%	88.0
Not Active	23328240	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23328708	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	94.0	CHEMBL5784	Homo sapiens	% Control	%	94.0
Not Active	23329249	CHEMBL4880956	ARK5(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	101.0	CHEMBL5784	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23329654	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23330122	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	95.0	CHEMBL5784	Homo sapiens	% Control	%	95.0
Not Active	23330878	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	97.0	CHEMBL5784	Homo sapiens	% Control	%	97.0
Not Active	23331346	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23331933	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23332401	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	51.3	CHEMBL5784	Homo sapiens	% Control	%	51.3
Not Active	23333117	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	93.2	CHEMBL5784	Homo sapiens	% Control	%	93.2
Not Active	23333756	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	97.0	CHEMBL5784	Homo sapiens	% Control	%	97.0
Not Active	23334224	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	90.0	CHEMBL5784	Homo sapiens	% Control	%	90.0
Not Active	23335203	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	91.0	CHEMBL5784	Homo sapiens	% Control	%	91.0
Not Active	23335671	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	96.0	CHEMBL5784	Homo sapiens	% Control	%	96.0
Not Active	23336298	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	87.0	CHEMBL5784	Homo sapiens	% Control	%	87.0
Not Active	23336766	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	82.0	CHEMBL5784	Homo sapiens	% Control	%	82.0
Not Active	23337702	CHEMBL4882073	NUAK1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.0	CHEMBL5784	Homo sapiens	% Ctrl	%	96.0
Not Active	23337847	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23338315	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	82.0	CHEMBL5784	Homo sapiens	% Control	%	82.0
Not Active	23338927	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23339395	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	77.0	CHEMBL5784	Homo sapiens	% Control	%	77.0
Not Active	23340032	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	91.0	CHEMBL5784	Homo sapiens	% Control	%	91.0
Not Active	23340500	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	85.0	CHEMBL5784	Homo sapiens	% Control	%	85.0
Not Active	23341157	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23341625	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	98.0	CHEMBL5784	Homo sapiens	% Control	%	98.0
Not Active	23342241	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23342709	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23343339	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23343807	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	70.0	CHEMBL5784	Homo sapiens	% Control	%	70.0
Not Active	23344445	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23345018	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	92.0	CHEMBL5784	Homo sapiens	% Control	%	92.0
Not Active	23345486	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	99.0	CHEMBL5784	Homo sapiens	% Control	%	99.0
Not Active	23346063	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23346532	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23347142	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	94.9	CHEMBL5784	Homo sapiens	% Control	%	94.9
Not Active	23347623	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23348202	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23348670	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	86.0	CHEMBL5784	Homo sapiens	% Control	%	86.0
Not Active	23349257	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	83.0	CHEMBL5784	Homo sapiens	% Control	%	83.0
Not Active	23349875	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23350343	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	92.0	CHEMBL5784	Homo sapiens	% Control	%	92.0
Not Active	23350948	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23351416	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23352155	CHEMBL4882844	NUAK1 (ARK5) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	14.5	CHEMBL5784	Homo sapiens	% Inhibition	%	14.5028
Not Active	23352440	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	92.0	CHEMBL5784	Homo sapiens	% Control	%	92.0
Not Active	23352908	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23353790	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23354258	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23354990	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23355458	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23356094	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23356562	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23357171	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23357818	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	86.0	CHEMBL5784	Homo sapiens	% Control	%	86.0
Not Active	23358286	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23358872	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	86.6	CHEMBL5784	Homo sapiens	% Control	%	86.6
Not Active	23359470	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	57.0	CHEMBL5784	Homo sapiens	% Control	%	57.0
Not Active	23359938	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	89.0	CHEMBL5784	Homo sapiens	% Control	%	89.0
Not Active	23360523	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	89.0	CHEMBL5784	Homo sapiens	% Control	%	89.0
Not Active	23360991	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23361564	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	83.0	CHEMBL5784	Homo sapiens	% Control	%	83.0
Not Active	23362100	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23362568	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	86.0	CHEMBL5784	Homo sapiens	% Control	%	86.0
Not Active	23364210	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23364678	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	98.0	CHEMBL5784	Homo sapiens	% Control	%	98.0
Not Active	23365417	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	80.0	CHEMBL5784	Homo sapiens	% Control	%	80.0
Not Active	23365960	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	84.0	CHEMBL5784	Homo sapiens	% Control	%	84.0
Not Active	23366550	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23367018	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23367472	CHEMBL4883825	ARK5 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	115.0	CHEMBL5784	Homo sapiens	% Residual activity with Skepinone-L	%	115.0
Not Active	23367896	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	95.0	CHEMBL5784	Homo sapiens	% Control	%	95.0
Not Active	23368364	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	92.0	CHEMBL5784	Homo sapiens	% Control	%	92.0
Not Active	23368963	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	93.0	CHEMBL5784	Homo sapiens	% Control	%	93.0
Not Active	23369431	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23369976	CHEMBL4884221	ARK5(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	21.0	CHEMBL5784	Homo sapiens	% residual kinase activity	%	21.0
Slightly Active	23370399	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	33.0	CHEMBL5784	Homo sapiens	% Control	%	33.0
Not Active	23370867	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	95.0	CHEMBL5784	Homo sapiens	% Control	%	95.0
Not Active	23371676	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	88.0	CHEMBL5784	Homo sapiens	% Control	%	88.0
Not Active	23372144	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
	23372834	CHEMBL4884799	NuaK1(NUA1LGF5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5784	Homo sapiens	pIC50		6.0
	23373243	CHEMBL4885090	NuaK1(NUA1LGF5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5784	Homo sapiens	pIC50		6.0
	23373600	CHEMBL4885377	NuaK1(NUA1LGF5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5784	Homo sapiens	pIC50		6.0
Not Active	23374915	CHEMBL4885909	ARK5 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	23.5	CHEMBL5784	Homo sapiens	% Inhibition	%	23.5
Not Active	23375323	CHEMBL4886305	NUAK family, SNF1-like kinase, 1 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	7.0	CHEMBL5784	Homo sapiens	% inhibition	%	7.0
Not Active	23375571	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23376039	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23376617	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Not Active	23377086	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	95.0	CHEMBL5784	Homo sapiens	% Control	%	95.0
Not Active	23377944	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	94.0	CHEMBL5784	Homo sapiens	% Control	%	94.0
Not Active	23378412	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	88.0	CHEMBL5784	Homo sapiens	% Control	%	88.0
Not Active	23379579	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	98.0	CHEMBL5784	Homo sapiens	% Control	%	98.0
Not Active	23380047	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	86.0	CHEMBL5784	Homo sapiens	% Control	%	86.0
Not Active	23380741	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	94.0	CHEMBL5784	Homo sapiens	% Control	%	94.0
Not Active	23381389	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	99.0	CHEMBL5784	Homo sapiens	% Control	%	99.0
Not Active	23381857	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5784	Homo sapiens	% Control	%	100.0
Slightly Active	23382481	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	31.0	CHEMBL5784	Homo sapiens	% Control	%	31.0
Slightly Active	23382949	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	21.0	CHEMBL5784	Homo sapiens	% Control	%	21.0
Not Active	23383909	CHEMBL4887524	NUAK1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	84.0	CHEMBL5784	Homo sapiens	% Ctrl	%	84.0
Not Active	23384181	CHEMBL4887776	ARK5(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	4.55	CHEMBL5784	Homo sapiens	% inhibition	%	4.55
Not Active	23384864	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	98.0	CHEMBL5784	Homo sapiens	% Control	%	98.0
Not Active	23385331	CHEMBL4879588	KinomeScan assay: inhibition of ARK5	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	99.0	CHEMBL5784	Homo sapiens	% Control	%	99.0
